View | Drug Trial ID | Treatment | Species | Trial Type | Finding | Descriptor | +/- | Frequency | Value | Value Units | Synonyms |
---|---|---|---|---|---|---|---|---|---|---|---|
View | 165 | NIMESULIDE | Human | Clinical | Liver :: biopsy :: Cholestasis | increased | Pos | 0.01 - < 0.1% | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: Clinical Chemistry :: Hepatic Necrosis | uncommon -> frequency | Pos | 1 - < 10% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | ||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: Clinical Chemistry :: Inflammation | uncommon -> frequency | Pos | 1 - < 10% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | ||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | 1 - < 10% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | ||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: biopsy :: Fibrosis | uncommon -> frequency | Pos | 1 - < 10% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | ||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: Clinical Chemistry :: Hepatocellular Damage | common -> frequency | Pos | 1 - < 10% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | ||
View | 15 | METHOTREXATE | Human | Unknown / Unspecified | Liver :: biopsy :: Steatosis/Fatty Liver | Pos | >= 10% | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | |||
View | 15 | METHOTREXATE | Human | Unknown / Unspecified | Liver :: biopsy :: Fibrosis | Pos | >= 10% | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | |||
View | 7 | FLUTAMIDE | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | 1 - < 10% | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | ||
View | 7 | FLUTAMIDE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Mixed Type Damage | uncommon -> frequency | Pos | 1 - < 10% | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | ||
View | 7 | FLUTAMIDE | Human | Unknown / Unspecified | Immune :: Other :: Hypersensitivity | rare -> frequency | Pos | 0.1 - < 1% | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | ||
View | 15 | METHOTREXATE | Human | Unknown / Unspecified | Liver :: biopsy :: Cirrhosis | rare -> frequency | Pos | 0.1 - < 1% | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | ||
View | 18 | BOSENTAN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | common -> frequency | Pos | >= 10% | Tracleer, Ro-47-0203-029, Bosentan, Ro-470203029 | ||
View | 18 | BOSENTAN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Mixed Type Damage | uncommon -> frequency | Pos | 1 - < 10% | Tracleer, Ro-47-0203-029, Bosentan, Ro-470203029 | ||
View | 23 | KETOCONAZOLE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | common -> frequency | Pos | >= 10% | Xolegel, SID50104730, SID11112822, SID90341325, Extina, Ketoconazole, Ketosidin, SID50104728, SID26719656, SID124882654, Nizoral A-D, SID11113916, Ketozole, SID50104729, SID124882653, SID11533029, SID26752071, SID11111347, SID26752070, R-41400, SID85267857, Nizoral, Panfungol, SID56422892, SID50104731 | ||
View | 23 | KETOCONAZOLE | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | 1 - < 10% | Xolegel, SID50104730, SID11112822, SID90341325, Extina, Ketoconazole, Ketosidin, SID50104728, SID26719656, SID124882654, Nizoral A-D, SID11113916, Ketozole, SID50104729, SID124882653, SID11533029, SID26752071, SID11111347, SID26752070, R-41400, SID85267857, Nizoral, Panfungol, SID56422892, SID50104731 | ||
View | 82 | NOMIFENSINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatoxicity | extensive | Pos | 1 - < 10% | Alival, SID50105261, Merital, Nomifensine, SID90340560 | ||
View | 47 | ACITRETIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | >= 10% | Acitretin, SID26756475, Soriatane, SID49640651, Ro-10-1670-000, SID29216416, Etretin, Ro-101670000 | |||
View | 47 | ACITRETIN | Human | Post-marketing | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | Acitretin, SID26756475, Soriatane, SID49640651, Ro-10-1670-000, SID29216416, Etretin, Ro-101670000 | |||
View | 64 | AMITRIPTYLINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | Amitriptyline, Limbitrol, Endep, Amitril, Etrafon-A, Elavil, Tryptanol, SID11110782, Amitid, Etrafon-Forte, SID90340850, SID11110783, AmitriptylineHCl | |||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: Clinical Chemistry :: Microvesicular Steatosis | uncommon -> frequency | Pos | 1 - < 10% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | ||
View | 166 | ACETAMINOPHEN | Rat | Preclinical | Liver :: Clinical Chemistry :: ALT | increased females only | Pos | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |||
View | 30 | NEVIRAPINE | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | common -> frequency | Pos | >= 10% | Viramune Xr, SID26719643, Nevirapine, SID865943, Viramune, BIRG-0587, SID49718173, SID17388862 | ||
View | 117 | TOLCAPONE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | >= 10% | Tasmar, Ro-407592, Tolcapone, SID144206516, Ro-40-7592, SID50126317 | |||
View | 123 | FELBAMATE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | common -> frequency | Pos | >= 10% | SID855835, SID11113343, SID56422162, Felbamate, Felbatol, W-554, SID50104096, SID144203696, SID90340922 | ||
View | 125 | LEVOFLOXACIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | Levofloxacin, Iquix, RWJ-25213, DR-3355, Levaquin, Quixin, SID49665952, Floxacin, SID26719895 | |||
View | 125 | LEVOFLOXACIN | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | Levofloxacin, Iquix, RWJ-25213, DR-3355, Levaquin, Quixin, SID49665952, Floxacin, SID26719895 | |||
View | 130 | ISONIAZID | Human | Unknown / Unspecified | Liver :: observation :: Jaundice | Pos | >= 10% | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | |||
View | 133 | MONTELUKAST | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | MK-476, Singulair, Montelukast, Montelo-10 | |||
View | 133 | MONTELUKAST | Human | Unknown / Unspecified | Liver :: Immunology :: Autoantibodies | rare -> frequency | Pos | 0.1 - < 1% | MK-476, Singulair, Montelukast, Montelo-10 | ||
View | 135 | FLUOXETINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | % | Prozac, Sarafem, Symbyax, SID104171153, SID26755310, SID26751973, SID50104648, Fluoxetine, SID90341619, SID144203695, Prozac Weekly, FluoxetineHCl | ||
View | 135 | FLUOXETINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | Prozac, Sarafem, Symbyax, SID104171153, SID26755310, SID26751973, SID50104648, Fluoxetine, SID90341619, SID144203695, Prozac Weekly, FluoxetineHCl | |||
View | 135 | FLUOXETINE | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | Prozac, Sarafem, Symbyax, SID104171153, SID26755310, SID26751973, SID50104648, Fluoxetine, SID90341619, SID144203695, Prozac Weekly, FluoxetineHCl | |||
View | 138 | SERTRALINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 0.1 - < 1% | SID50105685, SID50105684, Zoloft, SID50105682, SID49665783, SID90341218, SID29215139, Sertraline, SID26753299, SID50105683 | |||
View | 138 | SERTRALINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | SID50105685, SID50105684, Zoloft, SID50105682, SID49665783, SID90341218, SID29215139, Sertraline, SID26753299, SID50105683 | |||
View | 143 | FAMOTIDINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | >= 10% | Pepcid Rpd, SID85231052, SID144203704, SID26753575, Fluxid, SID11111194, Pepcid, SID50106279, SID26748463, SID11111195, MK-208, SID49681730, SID855518, Famotidine, Pepcid Ac | |||
View | 145 | GABAPENTIN | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | SID90340599, SID50103936, SID11112806, SID11113327, SID104171164, Gabapentin, Neurontin, SID855579, CI-945, GOE-3450, Gralise | |||
View | 147 | DIDANOSINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | |||
View | 147 | DIDANOSINE | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | |||
View | 151 | LOVASTATIN | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | >= 10% | SID17389841, SID26751557, Altoprev, SID49732779, SID855905, Lovastatin, SID496591, MK-803, Mevacor, Mevinolin, SID144204439 | |||
View | 151 | LOVASTATIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | SID17389841, SID26751557, Altoprev, SID49732779, SID855905, Lovastatin, SID496591, MK-803, Mevacor, Mevinolin, SID144204439 | |||
View | 151 | LOVASTATIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | SID17389841, SID26751557, Altoprev, SID49732779, SID855905, Lovastatin, SID496591, MK-803, Mevacor, Mevinolin, SID144204439 | |||
View | 151 | LOVASTATIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: ALT | Pos | 0.1 - < 1% | SID17389841, SID26751557, Altoprev, SID49732779, SID855905, Lovastatin, SID496591, MK-803, Mevacor, Mevinolin, SID144204439 | |||
View | 153 | PIOGLITAZONE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | Actos, SID137275816, SID26756476, Pioglitazone, Duetact | |||
View | 160 | SIMVASTATIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | MK-733, Synvinolin, Simvastatin, Simvastatin hydroxy acid, SID496592, Zocor, SID50086525, SID144204247 | |||
View | 160 | SIMVASTATIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | MK-733, Synvinolin, Simvastatin, Simvastatin hydroxy acid, SID496592, Zocor, SID50086525, SID144204247 | |||
View | 160 | SIMVASTATIN | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | MK-733, Synvinolin, Simvastatin, Simvastatin hydroxy acid, SID496592, Zocor, SID50086525, SID144204247 | |||
View | 162 | FLUVASTATIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Fluvastatin | |||
View | 162 | FLUVASTATIN | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | Fluvastatin | |||
View | 123 | FELBAMATE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Liver Function Test | uncommon -> frequency | Pos | 1 - < 10% | SID855835, SID11113343, SID56422162, Felbamate, Felbatol, W-554, SID50104096, SID144203696, SID90340922 | ||
View | 130 | ISONIAZID | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | |||
View | 130 | ISONIAZID | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Bilirubin | Pos | 1 - < 10% | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | |||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: PK :: Cyp P450 Metabolism | Pos | < 0.01% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | |||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: PK :: Biliary elimination | Pos | < 0.01% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | |||
View | 5 | VALPROIC ACID | Human | Clinical | Kidney :: PK :: Urinary Elimination | Pos | < 0.01% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | |||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: Clinical Chemistry :: Liver Function Test | Pos | < 0.01% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | |||
View | 7 | FLUTAMIDE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | |||
View | 10 | DANTROLENE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 0.1 - < 1% | F-368, SID26756482, Dantrolene, Dantamacrin, SID26756773, Dantrium, DantroleneNa | |||
View | 15 | METHOTREXATE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | |||
View | 18 | BOSENTAN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | Tracleer, Ro-47-0203-029, Bosentan, Ro-470203029 | |||
View | 23 | KETOCONAZOLE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | Xolegel, SID50104730, SID11112822, SID90341325, Extina, Ketoconazole, Ketosidin, SID50104728, SID26719656, SID124882654, Nizoral A-D, SID11113916, Ketozole, SID50104729, SID124882653, SID11533029, SID26752071, SID11111347, SID26752070, R-41400, SID85267857, Nizoral, Panfungol, SID56422892, SID50104731 | |||
View | 28 | NALTREXONE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | Celupan, EN-1639A, Revia, Naltrexone, EN-1639A [As Hydrochloride], Vivitrol, Trexal, Trexan | |||
View | 30 | NEVIRAPINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: ALT | Pos | >= 10% | Viramune Xr, SID26719643, Nevirapine, SID865943, Viramune, BIRG-0587, SID49718173, SID17388862 | |||
View | 47 | ACITRETIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Liver Function Test | Pos | 1 - < 10% | Acitretin, SID26756475, Soriatane, SID49640651, Ro-10-1670-000, SID29216416, Etretin, Ro-101670000 | |||
View | 52 | NADOLOL | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | 0.5 | % | Nadolol, SQ-11725, SID855594, SID56422422, Corgard | |
View | 7 | FLUTAMIDE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | |||
View | 10 | DANTROLENE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | F-368, SID26756482, Dantrolene, Dantamacrin, SID26756773, Dantrium, DantroleneNa | |||
View | 40 | ATENOLOL | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Esatenolol, Unibloc, SID50104387, Tenormin, ICI-66082, SID90340978, SID855957, SID26751696, Atenolol, SID50085956, Ibinolo | |||
View | 46 | DESIPRAMINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | |||
View | 64 | AMITRIPTYLINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | Amitriptyline, Limbitrol, Endep, Amitril, Etrafon-A, Elavil, Tryptanol, SID11110782, Amitid, Etrafon-Forte, SID90340850, SID11110783, AmitriptylineHCl | |||
View | 70 | PAROXETINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | BRL-29060, Paroxetine, Paxil, SID50104981, SID26752262, SID144206674, SID50104978, SID50104979, SID50104980, SID29215051, SID90341371, Paxil [as hydrochloride], Pexeva | |||
View | 73 | ROFECOXIB | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | |||
View | 75 | ROFECOXIB | Human | Post-marketing | Liver :: Clinical Chemistry :: ALT | Pos | >= 10% | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | |||
View | 75 | ROFECOXIB | Human | Post-marketing | Liver :: Clinical Chemistry :: Liver Function Test | Pos | < 0.01% | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | |||
View | 28 | NALTREXONE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Celupan, EN-1639A, Revia, Naltrexone, EN-1639A [As Hydrochloride], Vivitrol, Trexal, Trexan | |||
View | 55 | ASPIRIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | >= 10% | Acetosalic Acid, Acetylsalicylic Acid, SID87798, SID17390036, Measurin, Ecotrin, SID85230910, SID26752858, 8-Hour Bayer, Salicylic Acid Acetate, SID90340586, SID47193676, SID17389202, Aspirin, Bayer Extra Strength, Equi-Prin, SID26747283, SID50105490, Acetylsalicylic acid | ||
View | 162 | FLUVASTATIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Fluvastatin | |||
View | 173 | NEFAZODONE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | increased | Pos | 1 - < 10% | Nefazodone, Serzone, SID50111710, SID49666410, Nefadar, Nefazodone Hydrochloride | ||
View | 173 | NEFAZODONE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatic Necrosis | increased | Pos | 0.1 - < 1% | Nefazodone, Serzone, SID50111710, SID49666410, Nefadar, Nefazodone Hydrochloride | ||
View | 173 | NEFAZODONE | Human | Post-marketing | Immune :: Other :: Hypersensitivity | increased | Pos | 0.1 - < 1% | Nefazodone, Serzone, SID50111710, SID49666410, Nefadar, Nefazodone Hydrochloride | ||
View | 173 | NEFAZODONE | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | 1 - < 10% | Nefazodone, Serzone, SID50111710, SID49666410, Nefadar, Nefazodone Hydrochloride | ||
View | 7 | FLUTAMIDE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | common -> frequency | Pos | >= 10% | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | ||
View | 83 | GEFITINIB | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | SID50100103, SID137275808, ZDJ-839, Gefitinib, SID29215403, SID144205236, SID103905344, SID103905343, Iressa, ZD-1839 | |||
View | 83 | GEFITINIB | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | SID50100103, SID137275808, ZDJ-839, Gefitinib, SID29215403, SID144205236, SID103905344, SID103905343, Iressa, ZD-1839 | |||
View | 93 | GREPAFLOXACIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | Grepafloxacin, SID50112780, Raxar, Vaxor | |||
View | 98 | CYCLOPHOSPHAMIDE | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | >= 10% | SID90341534, SID87150, Cyclophosphamide, Neosar, SID85230959, SID50105634, Sendoxan, Cytoxan | |||
View | 108 | PERGOLIDE | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | < 0.01% | Pergolide, Pergotoliderived, SID104171354, SID26754330, SID26754331, SID90341767, Permax | |||
View | 30 | NEVIRAPINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Viramune Xr, SID26719643, Nevirapine, SID865943, Viramune, BIRG-0587, SID49718173, SID17388862 | |||
View | 30 | NEVIRAPINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 0.1 - < 1% | Viramune Xr, SID26719643, Nevirapine, SID865943, Viramune, BIRG-0587, SID49718173, SID17388862 | |||
View | 125 | LEVOFLOXACIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Levofloxacin, Iquix, RWJ-25213, DR-3355, Levaquin, Quixin, SID49665952, Floxacin, SID26719895 | |||
View | 96 | BLEOMYCIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | >= 10% | Blenoxane, Bleomycin sulfate | ||
View | 96 | BLEOMYCIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | 1 - < 10% | 500.0 | % | Blenoxane, Bleomycin sulfate |
View | 121 | BUSPIRONE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | 1 - < 10% | Buspar, SID11110857, SID11112732, SID26751994, SID11113821, Buspirone, SID90340780, SID104171117, BuspironeHCl | ||
View | 35 | FLUVASTATIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | 1 - < 10% | Fluvastatin | ||
View | 35 | FLUVASTATIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | 1 - < 10% | 300.0 | % | Fluvastatin |
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: Clinical Chemistry :: Mitochondrial Toxicity | likely | Pos | 1 - < 10% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | ||
View | 15 | METHOTREXATE | Human | Unknown / Unspecified | Liver :: biopsy :: Fibrosis | Pos | >= 10% | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | |||
View | 10 | DANTROLENE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | common -> frequency | Pos | >= 10% | F-368, SID26756482, Dantrolene, Dantamacrin, SID26756773, Dantrium, DantroleneNa | ||
View | 23 | KETOCONAZOLE | Human | Unknown / Unspecified | Immune :: Other :: Hypersensitivity | rare -> frequency | Pos | 0.1 - < 1% | Xolegel, SID50104730, SID11112822, SID90341325, Extina, Ketoconazole, Ketosidin, SID50104728, SID26719656, SID124882654, Nizoral A-D, SID11113916, Ketozole, SID50104729, SID124882653, SID11533029, SID26752071, SID11111347, SID26752070, R-41400, SID85267857, Nizoral, Panfungol, SID56422892, SID50104731 | ||
View | 64 | AMITRIPTYLINE | Human | Post-marketing | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | Amitriptyline, Limbitrol, Endep, Amitril, Etrafon-A, Elavil, Tryptanol, SID11110782, Amitid, Etrafon-Forte, SID90340850, SID11110783, AmitriptylineHCl | |||
View | 30 | NEVIRAPINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | 1 - < 10% | Viramune Xr, SID26719643, Nevirapine, SID865943, Viramune, BIRG-0587, SID49718173, SID17388862 | ||
View | 130 | ISONIAZID | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | >= 10% | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | |||
View | 133 | MONTELUKAST | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | MK-476, Singulair, Montelukast, Montelo-10 | |||
View | 138 | SERTRALINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | SID50105685, SID50105684, Zoloft, SID50105682, SID49665783, SID90341218, SID29215139, Sertraline, SID26753299, SID50105683 | |||
View | 143 | FAMOTIDINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Pepcid Rpd, SID85231052, SID144203704, SID26753575, Fluxid, SID11111194, Pepcid, SID50106279, SID26748463, SID11111195, MK-208, SID49681730, SID855518, Famotidine, Pepcid Ac | |||
View | 147 | DIDANOSINE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | 1 - < 10% | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | |||
View | 153 | PIOGLITAZONE | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | 1 - < 10% | Actos, SID137275816, SID26756476, Pioglitazone, Duetact | |||
View | 160 | SIMVASTATIN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | MK-733, Synvinolin, Simvastatin, Simvastatin hydroxy acid, SID496592, Zocor, SID50086525, SID144204247 | |||
View | 130 | ISONIAZID | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | |||
View | 5 | VALPROIC ACID | Human | Clinical | Liver :: Clinical Chemistry :: Bilirubin | Pos | 1 - < 10% | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | |||
View | 7 | FLUTAMIDE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | |||
View | 18 | BOSENTAN | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Tracleer, Ro-47-0203-029, Bosentan, Ro-470203029 | |||
View | 47 | ACITRETIN | Human | Post-marketing | Liver :: Clinical Chemistry :: ALT | Pos | >= 10% | 45.0 | IU/L | Acitretin, SID26756475, Soriatane, SID49640651, Ro-10-1670-000, SID29216416, Etretin, Ro-101670000 | |
View | 15 | METHOTREXATE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | |||
View | 43 | PROPRANOLOL | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Propranolol, SID26751802, Inderide-40/25, SID124881056, Innopran Xl, Inderal, SID50104497, Inderide-80/25, SID90341556, SID26755283 | |||
View | 74 | CIMETIDINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | SID17389962, Cimetidine, Valmagen, SID104171130, SID11113773, SID90341189, SID26751957, SID50104629, SID460110, SID11533056, SID56462993, Brumetadina, Tagamet HB, SID26747359, Tagamet, Tagamet HB 200 | |||
View | 117 | TOLCAPONE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | 1 - < 10% | Tasmar, Ro-407592, Tolcapone, SID144206516, Ro-40-7592, SID50126317 | |||
View | 110 | CIPROFLOXACIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | 1 - < 10% | BAY-Q-3939, Ciloxan, Ciprobay, Velmonit, SID11112875, SID26748814, Cipro, Ciprofloxacin, SID124882697 | ||
View | 172 | TROGLITAZONE | Human | Clinical | Liver :: Clinical Chemistry :: ALT | increased | Pos | 1 - < 10% | 1.9 | % | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 |
View | 172 | TROGLITAZONE | Human | Clinical | Liver :: Clinical Chemistry :: AST | increased | Pos | 0.01 - < 0.1% | 0.5 | % | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 |
View | 165 | NIMESULIDE | Human | Clinical | Liver :: Clinical Chemistry :: Liver Function Test | increased | Pos | 1 - < 10% | 1.0 | % | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 |
View | 5 | VALPROIC ACID | Human | Clinical | Blood :: PK :: Plasma Protein Binding | Pos | < 0.01% | 90.0 | % | SID26752921, SID90341449, Depakene, Valproic Acid, Valproic acid, SID399407, Stavzor, SID17389523, 44089, Valproate | |
View | 7 | FLUTAMIDE | Human | Unknown / Unspecified | Liver :: mechanism :: Reactive Intermediate | Pos | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | ||||
View | 10 | DANTROLENE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Hepatic Necrosis | Pos | F-368, SID26756482, Dantrolene, Dantamacrin, SID26756773, Dantrium, DantroleneNa | ||||
View | 10 | DANTROLENE | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | F-368, SID26756482, Dantrolene, Dantamacrin, SID26756773, Dantrium, DantroleneNa | ||||
View | 10 | DANTROLENE | Human | Unknown / Unspecified | Immune :: Other :: Hypersensitivity | Pos | F-368, SID26756482, Dantrolene, Dantamacrin, SID26756773, Dantrium, DantroleneNa | ||||
View | 10 | DANTROLENE | Human | Unknown / Unspecified | Liver :: mechanism :: Reactive Intermediate | Pos | F-368, SID26756482, Dantrolene, Dantamacrin, SID26756773, Dantrium, DantroleneNa | ||||
View | 21 | BOSENTAN | Rat | Preclinical | Liver :: Clinical Chemistry :: Liver Weight | Pos | Tracleer, Ro-47-0203-029, Bosentan, Ro-470203029 | ||||
View | 21 | BOSENTAN | Rat | Preclinical | Liver :: Clinical Chemistry :: No Finding | Pos | Tracleer, Ro-47-0203-029, Bosentan, Ro-470203029 | ||||
View | 30 | NEVIRAPINE | Human | Unknown / Unspecified | Immune :: Other :: Hypersensitivity | Pos | Viramune Xr, SID26719643, Nevirapine, SID865943, Viramune, BIRG-0587, SID49718173, SID17388862 | ||||
View | 48 | DESIPRAMINE | Human | Clinical | Liver :: mechanism :: Reactive Intermediate | Pos | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | ||||
View | 46 | DESIPRAMINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | |||
View | 46 | DESIPRAMINE | Human | Post-marketing | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | |||
View | 46 | DESIPRAMINE | Human | Post-marketing | Immune :: Other :: Hypersensitivity | common -> frequency | Pos | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | |||
View | 46 | DESIPRAMINE | Human | Post-marketing | Liver :: Immunology :: Autoantibodies | rare -> frequency | Pos | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | |||
View | 56 | ROSIGLITAZONE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | Avandaryl, Avandia, Rosiglitazone, SID26748954, SID144204987, Avandamet, BRL-49653 | |||
View | 60 | CISPLATIN | Human | Post-marketing | Liver :: biopsy :: Steatosis/Fatty Liver | increased | Pos | SID557830, SID50105439, CIS-DDP, SID301178, Cis-Platinum II, SID90340859, SID17389100, Platinol, Cisplatin | |||
View | 60 | CISPLATIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatic Necrosis | increased | Pos | SID557830, SID50105439, CIS-DDP, SID301178, Cis-Platinum II, SID90340859, SID17389100, Platinol, Cisplatin | |||
View | 64 | AMITRIPTYLINE | Human | Post-marketing | Immune :: Other :: Hypersensitivity | Pos | Amitriptyline, Limbitrol, Endep, Amitril, Etrafon-A, Elavil, Tryptanol, SID11110782, Amitid, Etrafon-Forte, SID90340850, SID11110783, AmitriptylineHCl | ||||
View | 64 | AMITRIPTYLINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Haptotype | Pos | Amitriptyline, Limbitrol, Endep, Amitril, Etrafon-A, Elavil, Tryptanol, SID11110782, Amitid, Etrafon-Forte, SID90340850, SID11110783, AmitriptylineHCl | ||||
View | 70 | PAROXETINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | BRL-29060, Paroxetine, Paxil, SID50104981, SID26752262, SID144206674, SID50104978, SID50104979, SID50104980, SID29215051, SID90341371, Paxil [as hydrochloride], Pexeva | |||
View | 70 | PAROXETINE | Human | Post-marketing | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | BRL-29060, Paroxetine, Paxil, SID50104981, SID26752262, SID144206674, SID50104978, SID50104979, SID50104980, SID29215051, SID90341371, Paxil [as hydrochloride], Pexeva | |||
View | 73 | ROFECOXIB | Human | Post-marketing | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | |||
View | 73 | ROFECOXIB | Human | Post-marketing | Immune :: Other :: Hypersensitivity | uncommon -> frequency | Pos | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | |||
View | 74 | CIMETIDINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | SID17389962, Cimetidine, Valmagen, SID104171130, SID11113773, SID90341189, SID26751957, SID50104629, SID460110, SID11533056, SID56462993, Brumetadina, Tagamet HB, SID26747359, Tagamet, Tagamet HB 200 | |||
View | 74 | CIMETIDINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatic Necrosis | Pos | SID17389962, Cimetidine, Valmagen, SID104171130, SID11113773, SID90341189, SID26751957, SID50104629, SID460110, SID11533056, SID56462993, Brumetadina, Tagamet HB, SID26747359, Tagamet, Tagamet HB 200 | ||||
View | 74 | CIMETIDINE | Human | Post-marketing | Immune :: Other :: Hypersensitivity | uncommon -> frequency | Pos | SID17389962, Cimetidine, Valmagen, SID104171130, SID11113773, SID90341189, SID26751957, SID50104629, SID460110, SID11533056, SID56462993, Brumetadina, Tagamet HB, SID26747359, Tagamet, Tagamet HB 200 | |||
View | 75 | ROFECOXIB | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatoxicity | rare -> frequency | Pos | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | |||
View | 75 | ROFECOXIB | Human | Post-marketing | Liver :: observation :: Jaundice | rare -> frequency | Pos | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | |||
View | 76 | ROFECOXIB | Rat | Post-marketing | Liver :: Clinical Chemistry :: No Finding | Neg | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | ||||
View | 77 | ROFECOXIB | Dog | Post-marketing | Liver :: Clinical Chemistry :: No Finding | Neg | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | ||||
View | 78 | CISAPRIDE | Human | Post-marketing | Liver :: biopsy :: Cholestasis | reversible | Pos | Propulsid, Cisapride, Risamal, R-51619, SID144204250, Acenalin | |||
View | 80 | TEMAFLOXACIN | Human | Clinical | Liver :: Clinical Chemistry :: No Finding | Neg | Omniflox, Temafloxacin, Temac | ||||
View | 81 | CHLORZOXAZONE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | Strifon Forte Dsc, Parafon Forte, Chlorzoxazone, Parafon Forte Dsc, Paraflex, SID11110946, Parafon, Strifon, Parafon-Forte, SID11110945 | |||
View | 81 | CHLORZOXAZONE | Human | Post-marketing | Immune :: Other :: Hypersensitivity | Pos | Strifon Forte Dsc, Parafon Forte, Chlorzoxazone, Parafon Forte Dsc, Paraflex, SID11110946, Parafon, Strifon, Parafon-Forte, SID11110945 | ||||
View | 83 | GEFITINIB | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | Pos | SID50100103, SID137275808, ZDJ-839, Gefitinib, SID29215403, SID144205236, SID103905344, SID103905343, Iressa, ZD-1839 | ||||
View | 87 | SIBUTRAMINE | Human | Post-marketing | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | Sibutramine, Meridia, SID49732001 | |||
View | 89 | CERIVASTATIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatoxicity | common -> frequency | Pos | SID50111694, Cerivastatin, Lipobay, Baycol | |||
View | 90 | TERFENADINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | Triludan, SID144203846, Seldane, RMI-9918, SID90341346, SID56422373, SID85231279, Terfenadine, SID26752308, SID855647, Teldane, SID104171258, SID144203847, SID50105228 | |||
View | 92 | PAROXETINE | Dog | Post-marketing | Liver :: Clinical Chemistry :: No Finding | Neg | BRL-29060, Paroxetine, Paxil, SID50104981, SID26752262, SID144206674, SID50104978, SID50104979, SID50104980, SID29215051, SID90341371, Paxil [as hydrochloride], Pexeva | ||||
View | 94 | GREPAFLOXACIN | Rat | Post-marketing | Liver :: Clinical Chemistry :: No Finding | Pos | Grepafloxacin, SID50112780, Raxar, Vaxor | ||||
View | 95 | GREPAFLOXACIN | Dog | Post-marketing | Liver :: Clinical Chemistry :: No Finding | Pos | Grepafloxacin, SID50112780, Raxar, Vaxor | ||||
View | 98 | CYCLOPHOSPHAMIDE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | SID90341534, SID87150, Cyclophosphamide, Neosar, SID85230959, SID50105634, Sendoxan, Cytoxan | |||
View | 102 | GENTAMICIN | Human | Post-marketing | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | Genoptic, Bristagen, SCH-9724, Apogen, Garacin, Gentacidin, Gentak, Uromycine, Gentafair, Gentamicin, U-Gencin | |||
View | 102 | GENTAMICIN | Human | Post-marketing | Immune :: Other :: Hypersensitivity | uncommon -> frequency | Pos | Genoptic, Bristagen, SCH-9724, Apogen, Garacin, Gentacidin, Gentak, Uromycine, Gentafair, Gentamicin, U-Gencin | |||
View | 106 | PRIMAQUINE | Human | Post-marketing | Liver :: Clinical Chemistry :: No Liver Effects | Neg | Primaquine, SID24715073, SID24715072 | ||||
View | 106 | PRIMAQUINE | Human | Post-marketing | Liver :: observation :: Jaundice | Pos | Primaquine, SID24715073, SID24715072 | ||||
View | 110 | CIPROFLOXACIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatocellular Damage | uncommon -> frequency | Pos | BAY-Q-3939, Ciloxan, Ciprobay, Velmonit, SID11112875, SID26748814, Cipro, Ciprofloxacin, SID124882697 | |||
View | 110 | CIPROFLOXACIN | Human | Post-marketing | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | BAY-Q-3939, Ciloxan, Ciprobay, Velmonit, SID11112875, SID26748814, Cipro, Ciprofloxacin, SID124882697 | |||
View | 110 | CIPROFLOXACIN | Human | Post-marketing | Immune :: Other :: Hypersensitivity | Pos | BAY-Q-3939, Ciloxan, Ciprobay, Velmonit, SID11112875, SID26748814, Cipro, Ciprofloxacin, SID124882697 | ||||
View | 116 | TOLCAPONE | Human | Post-marketing | Liver :: observation :: Jaundice | Pos | Tasmar, Ro-407592, Tolcapone, SID144206516, Ro-40-7592, SID50126317 | ||||
View | 116 | TOLCAPONE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatitis | Pos | Tasmar, Ro-407592, Tolcapone, SID144206516, Ro-40-7592, SID50126317 | ||||
View | 123 | FELBAMATE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Inflammation | Pos | SID855835, SID11113343, SID56422162, Felbamate, Felbatol, W-554, SID50104096, SID144203696, SID90340922 | ||||
View | 130 | ISONIAZID | Human | Unknown / Unspecified | Immune :: Other :: Hypersensitivity | Pos | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | ||||
View | 133 | MONTELUKAST | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Transaminases | Pos | MK-476, Singulair, Montelukast, Montelo-10 | ||||
View | 138 | SERTRALINE | Human | Unknown / Unspecified | Liver :: biopsy :: Cholestasis | Pos | SID50105685, SID50105684, Zoloft, SID50105682, SID49665783, SID90341218, SID29215139, Sertraline, SID26753299, SID50105683 | ||||
View | 147 | DIDANOSINE | Human | Unknown / Unspecified | Liver :: biopsy :: Steatosis/Fatty Liver | Pos | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | ||||
View | 148 | DIDANOSINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatoxicity | Pos | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | ||||
View | 148 | DIDANOSINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatitis | Pos | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | ||||
View | 148 | DIDANOSINE | Human | Post-marketing | Liver :: biopsy :: Steatosis/Fatty Liver | Pos | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | ||||
View | 130 | ISONIAZID | Human | Unknown / Unspecified | Liver :: Immunology :: Autoantibodies | Pos | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | ||||
View | 15 | METHOTREXATE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: ALT | Pos | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | ||||
View | 18 | BOSENTAN | Human | Unknown / Unspecified | Liver :: PK :: Induction | Pos | Tracleer, Ro-47-0203-029, Bosentan, Ro-470203029 | ||||
View | 18 | BOSENTAN | Human | Unknown / Unspecified | Liver :: PK :: Cyp P450 Metabolism | Pos | Tracleer, Ro-47-0203-029, Bosentan, Ro-470203029 | ||||
View | 30 | NEVIRAPINE | Human | Unknown / Unspecified | Liver :: PK :: Induction | Pos | Viramune Xr, SID26719643, Nevirapine, SID865943, Viramune, BIRG-0587, SID49718173, SID17388862 | ||||
View | 55 | ASPIRIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Alkaline Phosphatase | Pos | Acetosalic Acid, Acetylsalicylic Acid, SID87798, SID17390036, Measurin, Ecotrin, SID85230910, SID26752858, 8-Hour Bayer, Salicylic Acid Acetate, SID90340586, SID47193676, SID17389202, Aspirin, Bayer Extra Strength, Equi-Prin, SID26747283, SID50105490, Acetylsalicylic acid | ||||
View | 55 | ASPIRIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Bilirubin | Pos | Acetosalic Acid, Acetylsalicylic Acid, SID87798, SID17390036, Measurin, Ecotrin, SID85230910, SID26752858, 8-Hour Bayer, Salicylic Acid Acetate, SID90340586, SID47193676, SID17389202, Aspirin, Bayer Extra Strength, Equi-Prin, SID26747283, SID50105490, Acetylsalicylic acid | ||||
View | 60 | CISPLATIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | SID557830, SID50105439, CIS-DDP, SID301178, Cis-Platinum II, SID90340859, SID17389100, Platinol, Cisplatin | ||||
View | 70 | PAROXETINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | Pos | BRL-29060, Paroxetine, Paxil, SID50104981, SID26752262, SID144206674, SID50104978, SID50104979, SID50104980, SID29215051, SID90341371, Paxil [as hydrochloride], Pexeva | ||||
View | 75 | ROFECOXIB | Human | Post-marketing | Liver :: PK :: Cyp P450 inhibition | Pos | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | ||||
View | 75 | ROFECOXIB | Human | Post-marketing | Systemic :: PK :: Bioavailability | Pos | 93.0 | % | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | ||
View | 75 | ROFECOXIB | Human | Post-marketing | Blood :: PK :: Plasma Protein Binding | Pos | 85.0 | % | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | ||
View | 55 | ASPIRIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | Acetosalic Acid, Acetylsalicylic Acid, SID87798, SID17390036, Measurin, Ecotrin, SID85230910, SID26752858, 8-Hour Bayer, Salicylic Acid Acetate, SID90340586, SID47193676, SID17389202, Aspirin, Bayer Extra Strength, Equi-Prin, SID26747283, SID50105490, Acetylsalicylic acid | |||
View | 166 | ACETAMINOPHEN | Rat | Preclinical | Liver :: Clinical Chemistry :: AST | increased females only | Pos | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |||
View | 166 | ACETAMINOPHEN | Rat | Preclinical | Liver :: Clinical Chemistry :: Alkaline Phosphatase | increased females only | Pos | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |||
View | 166 | ACETAMINOPHEN | Rat | Preclinical | Liver :: Clinical Chemistry :: Bilirubin | increased females only | Pos | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |||
View | 171 | CAFFEINE | Human | Unknown / Unspecified | None :: Other :: Fatal | Pos | 57.0 | mg/kg | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | ||
View | 173 | NEFAZODONE | Human | Post-marketing | Liver :: mechanism :: Reactive Intermediate | likely | Pos | Nefazodone, Serzone, SID50111710, SID49666410, Nefadar, Nefazodone Hydrochloride | |||
View | 75 | ROFECOXIB | Human | Post-marketing | Kidney :: PK :: Urinary Elimination | Pos | 72.0 | % | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | ||
View | 75 | ROFECOXIB | Human | Post-marketing | Liver :: PK :: Biliary elimination | Pos | 14.0 | % | Rofecoxib, SID26748942, SID49665949, Vioxx, MK-0966, MK-966, SID535364 | ||
View | 78 | CISAPRIDE | Human | Post-marketing | Systemic :: PK :: Bioavailability | Pos | 45.0 | % | Propulsid, Cisapride, Risamal, R-51619, SID144204250, Acenalin | ||
View | 78 | CISAPRIDE | Human | Post-marketing | Liver :: PK :: Biliary elimination | Pos | 50.0 | % | Propulsid, Cisapride, Risamal, R-51619, SID144204250, Acenalin | ||
View | 78 | CISAPRIDE | Human | Post-marketing | Kidney :: PK :: Urinary Elimination | Pos | 50.0 | % | Propulsid, Cisapride, Risamal, R-51619, SID144204250, Acenalin | ||
View | 78 | CISAPRIDE | Human | Post-marketing | Blood :: PK :: Plasma Protein Binding | Pos | 97.5 | % | Propulsid, Cisapride, Risamal, R-51619, SID144204250, Acenalin | ||
View | 79 | PHENYLBUTAZONE | Human | Post-marketing | Liver :: PK :: Cyp P450 inhibition | Pos | 80.0 | % | Elmedal, SID144203794, Pro-Bute, Azolid, SID17389760, Diphenylbutazone, Equiphar, SID50104199, SID85231197, Butaject, SID56436656, SID104171221, Butazolidin, Phenylbutazone, Antadol, SID855958, SID11111674, SID26751573, SID26747057, SID104171220, SID90341773 | ||
View | 79 | PHENYLBUTAZONE | Human | Post-marketing | Blood :: PK :: Plasma Protein Binding | Pos | 90.0 | % | Elmedal, SID144203794, Pro-Bute, Azolid, SID17389760, Diphenylbutazone, Equiphar, SID50104199, SID85231197, Butaject, SID56436656, SID104171221, Butazolidin, Phenylbutazone, Antadol, SID855958, SID11111674, SID26751573, SID26747057, SID104171220, SID90341773 | ||
View | 79 | PHENYLBUTAZONE | Human | Post-marketing | Liver :: PK :: Biliary elimination | Pos | 10.0 | % | Elmedal, SID144203794, Pro-Bute, Azolid, SID17389760, Diphenylbutazone, Equiphar, SID50104199, SID85231197, Butaject, SID56436656, SID104171221, Butazolidin, Phenylbutazone, Antadol, SID855958, SID11111674, SID26751573, SID26747057, SID104171220, SID90341773 | ||
View | 79 | PHENYLBUTAZONE | Human | Post-marketing | Kidney :: PK :: Urinary Elimination | Pos | 90.0 | % | Elmedal, SID144203794, Pro-Bute, Azolid, SID17389760, Diphenylbutazone, Equiphar, SID50104199, SID85231197, Butaject, SID56436656, SID104171221, Butazolidin, Phenylbutazone, Antadol, SID855958, SID11111674, SID26751573, SID26747057, SID104171220, SID90341773 | ||
View | 88 | SIBUTRAMINE | Human | Post-marketing | Systemic :: PK :: Bioavailability | Pos | 24.0 | % | Sibutramine, Meridia, SID49732001 | ||
View | 88 | SIBUTRAMINE | Human | Post-marketing | Blood :: PK :: Plasma Protein Binding | Pos | 97.0 | % | Sibutramine, Meridia, SID49732001 | ||
View | 89 | CERIVASTATIN | Human | Post-marketing | Systemic :: PK :: Bioavailability | Pos | 60.0 | % | SID50111694, Cerivastatin, Lipobay, Baycol | ||
View | 89 | CERIVASTATIN | Human | Post-marketing | Liver :: PK :: Biliary elimination | Pos | 70.0 | % | SID50111694, Cerivastatin, Lipobay, Baycol | ||
View | 74 | CIMETIDINE | Human | Post-marketing | Liver :: biopsy :: Cholestasis | uncommon -> frequency | Pos | SID17389962, Cimetidine, Valmagen, SID104171130, SID11113773, SID90341189, SID26751957, SID50104629, SID460110, SID11533056, SID56462993, Brumetadina, Tagamet HB, SID26747359, Tagamet, Tagamet HB 200 | |||
View | 89 | CERIVASTATIN | Human | Post-marketing | Kidney :: PK :: Urinary Elimination | Pos | 30.0 | % | SID50111694, Cerivastatin, Lipobay, Baycol | ||
View | 90 | TERFENADINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Liver Function Test | Neg | Triludan, SID144203846, Seldane, RMI-9918, SID90341346, SID56422373, SID85231279, Terfenadine, SID26752308, SID855647, Teldane, SID104171258, SID144203847, SID50105228 | ||||
View | 91 | TERFENADINE | Human | Post-marketing | Systemic :: PK :: Bioavailability | Pos | 1.0 | % | Triludan, SID144203846, Seldane, RMI-9918, SID90341346, SID56422373, SID85231279, Terfenadine, SID26752308, SID855647, Teldane, SID104171258, SID144203847, SID50105228 | ||
View | 93 | GREPAFLOXACIN | Human | Post-marketing | Kidney :: PK :: Urinary Elimination | Pos | 12.6 | % | Grepafloxacin, SID50112780, Raxar, Vaxor | ||
View | 93 | GREPAFLOXACIN | Human | Post-marketing | Liver :: PK :: Biliary elimination | Pos | 31.5 | % | Grepafloxacin, SID50112780, Raxar, Vaxor | ||
View | 102 | GENTAMICIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Alkaline Phosphatase | Pos | Genoptic, Bristagen, SCH-9724, Apogen, Garacin, Gentacidin, Gentak, Uromycine, Gentafair, Gentamicin, U-Gencin | ||||
View | 117 | TOLCAPONE | Human | Unknown / Unspecified | Liver :: Clinical Chemistry :: Glucuronidation | Pos | Tasmar, Ro-407592, Tolcapone, SID144206516, Ro-40-7592, SID50126317 | ||||
View | 60 | CISPLATIN | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatoxicity | rare -> frequency | Pos | SID557830, SID50105439, CIS-DDP, SID301178, Cis-Platinum II, SID90340859, SID17389100, Platinol, Cisplatin | |||
View | 46 | DESIPRAMINE | Human | Post-marketing | Liver :: Clinical Chemistry :: Liver Function Test | abnormal | Pos | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | |||
View | 169 | NIMESULIDE | Rat | Preclinical | None :: Other :: LD50 Oral | Pos | 200.0 | mg/kg | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||
View | 174 | ENTACAPONE | Human | Clinical | Liver :: Clinical Chemistry :: Glucuronidation | increased | Pos | Comtan, Entacapone, OR-611, SID26757974 | |||
View | 174 | ENTACAPONE | Human | Clinical | Liver :: PK :: Cyp P450 Metabolism | extensive | Pos | Comtan, Entacapone, OR-611, SID26757974 | |||
View | 174 | ENTACAPONE | Human | Clinical | Systemic :: PK :: Bioavailability | Pos | 29.0 | % | Comtan, Entacapone, OR-611, SID26757974 | ||
View | 174 | ENTACAPONE | Human | Clinical | None :: PK :: Protein Binding | extensive | Pos | 98.0 | % | Comtan, Entacapone, OR-611, SID26757974 | |
View | 172 | TROGLITAZONE | Human | Clinical | Systemic :: PK :: Bioavailability | Pos | 50.0 | % | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||
View | 172 | TROGLITAZONE | Human | Clinical | Liver :: Clinical Chemistry :: Glucuronidation | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||||
View | 172 | TROGLITAZONE | Human | Clinical | Liver :: mechanism :: Reactive Intermediate | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||||
View | 172 | TROGLITAZONE | Human | Clinical | Liver :: PK :: Sulfation | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||||
View | 172 | TROGLITAZONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 2.82 | µg/mL | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||
View | 174 | ENTACAPONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.22 | µg/mL | Comtan, Entacapone, OR-611, SID26757974 | ||
View | 178 | TOLCAPONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 7.2 | µg/mL | Tasmar, Ro-407592, Tolcapone, SID144206516, Ro-40-7592, SID50126317 | ||
View | 177 | ENTACAPONE | Dog | Preclinical | Multiple Organs :: Other :: No Toxicity | Neg | Comtan, Entacapone, OR-611, SID26757974 | ||||
View | 176 | ENTACAPONE | Rat | Preclinical | Multiple Organs :: Other :: No Toxicity | Neg | Comtan, Entacapone, OR-611, SID26757974 | ||||
View | 179 | TROGLITAZONE | Human | Post-marketing | None :: Other :: Fatal | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||||
View | 179 | TROGLITAZONE | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatic Necrosis | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||||
View | 179 | TROGLITAZONE | Human | Post-marketing | Liver :: Clinical Chemistry :: Inflammation | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||||
View | 179 | TROGLITAZONE | Human | Post-marketing | Liver :: mechanism :: Reactive Intermediate | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||||
View | 180 | TROGLITAZONE | Rat | Preclinical | Liver :: Clinical Chemistry :: Liver Weight | increased | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | |||
View | 180 | TROGLITAZONE | Rat | Preclinical | Systemic :: Hematology :: RBC, HGB, HCT | decreased | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | |||
View | 171 | CAFFEINE | Human | Unknown / Unspecified | Blood :: PK :: T1/2 | Pos | 4.2 | hours | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | ||
View | 181 | CAFFEINE | Human | Post-marketing | Heart :: observation :: Cardiac Arrhythmia | increased | Pos | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | |||
View | 182 | CAFFEINE | Rat | Preclinical | Systemic :: Other :: Body Weights | decreased | Pos | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | |||
View | 182 | CAFFEINE | Rat | Preclinical | Multiple Organs :: Other :: No Toxicity | Pos | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | ||||
View | 182 | CAFFEINE | Rat | Preclinical | Systemic :: observation :: NOAEL | male | Pos | 151.0 | mg/kg/day | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | |
View | 182 | CAFFEINE | Rat | Preclinical | Systemic :: observation :: NOAEL | female | Pos | 174.0 | mg/kg/day | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | |
View | 183 | CAFFEINE | Human | Clinical | Systemic :: PK :: Bioavailability | well absorbed | Pos | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | |||
View | 183 | CAFFEINE | Human | Clinical | Kidney :: PK :: Renal Clearance | extensive | Pos | 95.0 | % | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | |
View | 165 | NIMESULIDE | Human | Clinical | Liver :: Clinical Chemistry :: Hepatitis | increased | Pos | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | |||
View | 165 | NIMESULIDE | Human | Clinical | Liver :: Clinical Chemistry :: Hepatocellular Damage | zonal | Pos | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | |||
View | 184 | NIMESULIDE | Human | Clinical | Blood :: PK :: T1/2 | Pos | 3.0 | hours | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||
View | 184 | NIMESULIDE | Human | Clinical | Blood :: PK :: Cmax | Pos | 6.5 | µg/mL | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||
View | 184 | NIMESULIDE | Human | Clinical | Blood :: PK :: Plasma Protein Binding | Pos | 99.0 | % | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||
View | 184 | NIMESULIDE | Human | Clinical | Liver :: PK :: Clearance (CL) | urinary | Pos | 56.0 | % | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | |
View | 184 | NIMESULIDE | Human | Clinical | Liver :: PK :: Clearance (CL) | bile/fecal | Pos | 27.0 | % | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | |
View | 184 | NIMESULIDE | Human | Clinical | Blood :: PK :: Vd | Pos | 0.3 | L/Kg | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||
View | 166 | ACETAMINOPHEN | Rat | Preclinical | Liver :: Clinical Chemistry :: Hepatic Necrosis | increased | Pos | 2000.0 | mg/kg/day | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |
View | 166 | ACETAMINOPHEN | Rat | Preclinical | Kidney :: Clinical Chemistry :: Nephrotoxicity | Pos | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||||
View | 166 | ACETAMINOPHEN | Rat | Preclinical | Liver :: mechanism :: Reactive Intermediate | Pos | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||||
View | 185 | ACETAMINOPHEN | Human | Post-marketing | Liver :: Clinical Chemistry :: Transaminases | increased | Pos | 39.0 | % | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |
View | 186 | ACETAMINOPHEN | Human | Post-marketing | Liver :: mechanism :: Reactive Intermediate | Pos | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||||
View | 186 | ACETAMINOPHEN | Human | Post-marketing | Liver :: Clinical Chemistry :: Hepatic Necrosis | extensive | Pos | 7.5 | g | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |
View | 187 | ACETAMINOPHEN | Human | Clinical | Blood :: PK :: T1/2 | Pos | 3.0 | hours | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||
View | 187 | ACETAMINOPHEN | Human | Clinical | Blood :: PK :: Cmax | Pos | 21.0 | µg/mL | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||
View | 187 | ACETAMINOPHEN | Human | Clinical | Blood :: PK :: Vd | Pos | 1.5 | L/Kg | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||
View | 187 | ACETAMINOPHEN | Human | Clinical | Liver :: PK :: Sulfation | Pos | 30.0 | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |||
View | 187 | ACETAMINOPHEN | Human | Clinical | Liver :: PK :: Clearance (CL) | Kidney | Pos | 95.0 | % | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | |
View | 187 | ACETAMINOPHEN | Human | Clinical | Liver :: PK :: Clearance (CL) | Pos | 25.0 | % | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||
View | 187 | ACETAMINOPHEN | Human | Clinical | Systemic :: PK :: Bioavailability | Pos | 75.0 | % | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||
View | 189 | NIMESULIDE | Rat | Preclinical | Kidney :: Clinical Chemistry :: Nephrotoxicity | Pos | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||||
View | 189 | NIMESULIDE | Rat | Preclinical | Gut :: observation :: Gastrointestinal Toxicity | Pos | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||||
View | 166 | ACETAMINOPHEN | Rat | Preclinical | Systemic :: observation :: NOAEL | Pos | 500.0 | mg/kg | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||
View | 167 | CAFFEINE | Rat | Preclinical | Systemic :: observation :: NOAEL | Pos | 167.0 | mg/kg/day | Coffeine, SID26732615, SID104171124, SID50105397, SID26752751, SID11110908, SID49718178, SID90341215, Methyltheobromine, SID50105398, Caffeine, Cafcit, SID17389997, Theine, SID124879556, NoDoz Caplets and Chewable Tablets | ||
View | 187 | ACETAMINOPHEN | Human | Clinical | Liver :: PK :: Sulfation | Pos | 70.0 | % | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||
View | 189 | NIMESULIDE | Rat | Preclinical | Liver :: Clinical Chemistry :: Hepatoxicity | Pos | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||||
View | 184 | NIMESULIDE | Human | Clinical | Liver :: PK :: Metabolic Elimination | extensive hydroxylation | Pos | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | |||
View | 194 | EXENATIDE | Human | Clinical | Liver :: MRI :: MRS | Pos | 4.0 | % | AC 2993, AC-2993, AC002993, AC2993, AC2993A, Bydureon, Byetta, EXENATIDE, EXENATIDE SYNTHETIC, Exenatide Synthetic, Exenatide synthetic | ||
View | 201 | Ethyl Eicosapentaenoic Acid | Human | Clinical | Liver :: Clinical Chemistry :: ALT | Change from baseline | Neg | 0.1592 | p-value | ||
View | 197 | Placebo | Human | Clinical | None :: observation :: ALSFRS-R | Change from baseline | Neg | -6.35 | Scaled Unit | ||
View | 196 | FINGOLIMOD | Human | Clinical | None :: observation :: ALSFRS-R | Drug vs Placebo | Pos | 0.78 | p-value | FINGOLIMOD, Fingolimod, GILENYA | |
View | 196 | Placebo | Human | Clinical | None :: observation :: ALSFRS-R | Total Score | Pos | 37.1 | Scaled Unit | ||
View | 196 | FINGOLIMOD | Human | Clinical | None :: observation :: ALSFRS-R | Total Score | Pos | 36.74 | Scaled Unit | FINGOLIMOD, Fingolimod, GILENYA | |
View | 197 | MCI-186 | Human | Clinical | None :: observation :: ALSFRS-R | Change from baseline | Neg | -5.7 | Scaled Unit | ||
View | 198 | IMIQUIMOD | Human | Clinical | Vasculature :: observation :: Total Serious Adverse Events | Drug vs Placebo | Pos | 0.0 | % | ALDARA, Aldara, IMIQUIMOD, R-837, S26308, ZYCLARA | |
View | 198 | IMIQUIMOD | Human | Clinical | Vasculature :: observation :: a* (Erythemia Score) | Placebo | Pos | 0.43 | Erythemia Score | ALDARA, Aldara, IMIQUIMOD, R-837, S26308, ZYCLARA | |
View | 198 | IMIQUIMOD | Human | Clinical | Vasculature :: observation :: ΔE (Difference in Color) | Pos | 4.08 | Erythemia Score | ALDARA, Aldara, IMIQUIMOD, R-837, S26308, ZYCLARA | ||
View | 198 | IMIQUIMOD | Human | Clinical | Vasculature :: observation :: ΔE (Difference in Color) | Pos | 2.59 | Erythemia Score | ALDARA, Aldara, IMIQUIMOD, R-837, S26308, ZYCLARA | ||
View | 200 | MK-4074 | Human | Clinical | Liver :: biopsy :: Steatosis/Fatty Liver | Change from baseline | Neg | 35.73 | % | ||
View | 200 | MK-4074 | Human | Clinical | Liver :: biopsy :: Steatosis/Fatty Liver | Drug vs Placebo | Neg | 0.001 | p-value | ||
View | 200 |
MK-4074
PIOGLITAZONE |
Human | Clinical | Liver :: biopsy :: Steatosis/Fatty Liver | Drug 1 vs Drug 2 | Neg | 0.007 | p-value | Actos, SID137275816, SID26756476, Pioglitazone, Duetact | |
View | 195 | EXENATIDE | Human | Clinical | Liver :: biopsy :: Steatosis/Fatty Liver | Pos | 100.0 | % | AC 2993, AC-2993, AC002993, AC2993, AC2993A, Bydureon, Byetta, EXENATIDE, EXENATIDE SYNTHETIC, Exenatide Synthetic, Exenatide synthetic | ||
View | 201 | Ethyl Eicosapentaenoic Acid | Human | Clinical | Liver :: Clinical Chemistry :: AST | Change from baseline | Pos | 0.0137 | p-value | ||
View | 195 | EXENATIDE | Human | Clinical | Liver :: biopsy :: Steatosis/Fatty Liver | Change from baseline | Pos | -1.5 | ΔNAS | AC 2993, AC-2993, AC002993, AC2993, AC2993A, Bydureon, Byetta, EXENATIDE, EXENATIDE SYNTHETIC, Exenatide Synthetic, Exenatide synthetic | |
View | 198 | IMIQUIMOD | Human | Clinical | Vasculature :: observation :: a* (Erythemia Score) | Drug | Pos | 1.27 | Erythemia Score | ALDARA, Aldara, IMIQUIMOD, R-837, S26308, ZYCLARA | |
View | 203 | Metreleptin | Human | Clinical | Liver :: Clinical Chemistry :: NAS Score | Pos | 0.015 | p-value | |||
View | 204 | Metreleptin | Human | Clinical | Liver :: Clinical Chemistry :: NAS Score | Change from baseline | Neg | ||||
View | 205 | EMRICASAN | Human | Clinical | Liver :: Clinical Chemistry :: ALT | Pos | 0.0195 | p-value | EMRICASAN, IDN 6556, PF 03491390 | ||
View | 206 | SILYBIN A | Human | Clinical | Liver :: Clinical Chemistry :: NAS Score | Neg | |||||
View | 207 | LCQ908 | Human | Clinical | Liver :: MRI :: Unspecified | Change from baseline | Neg | 0.3128 | p-value | ||
View | 208 | SITAGLIPTIN PHOSPHATE | Human | Clinical | Liver :: MRI :: PDFF | Change from baseline | Neg | 0.585 | p-value | ||
View | 209 | OBETICHOLIC ACID | Human | Clinical | Liver :: Clinical Chemistry :: NAS Score | Change from baseline | Pos | 0.0002 | p-value | DSP-1747, INT-747, OBETICHOLIC ACID | |
View | 210 | Pentoxifylline | Human | Clinical | Liver :: Clinical Chemistry :: NAS Score | Change from baseline | Neg | -1.6 | ΔNAS | ||
View | 211 | Pentoxifylline | Human | Clinical | Liver :: Clinical Chemistry :: ALT | Change from baseline | Neg | 0.46 | p-value | ||
View | 212 | PIOGLITAZONE | Human | Clinical | Liver :: Clinical Chemistry :: NAS Score | Change from baseline | Pos | 66.666 | % | Actos, SID137275816, SID26756476, Pioglitazone, Duetact | |
View | 213 | PIOGLITAZONE | Human | Clinical | Liver :: biopsy :: Steatosis/Fatty Liver | Change from baseline | Pos | 0.001 | p-value | Actos, SID137275816, SID26756476, Pioglitazone, Duetact | |
View | 201 | Ethyl Eicosapentaenoic Acid | Human | Clinical | Liver :: biopsy :: Steatosis/Fatty Liver | Change from baseline | Neg | 0.57 | p-value | ||
View | 217 | Human | Clinical | Vasculature :: observation :: unspecified | Change from baseline | Pos | |||||
View | 219 | Human | Clinical | Multiple Organs :: observation :: Pain | Change from baseline | Pos | -2.57 | ||||
View | 220 | HYALURONIC ACID 8.0 mL | Human | Clinical | Multiple Organs :: observation :: Pain | Drug | Neg | 0.696 | p-value | Hyaluronic Acid | |
View | 220 | HYALURONIC ACID 8.0 mL | Human | Clinical | Multiple Organs :: observation :: Pain | Drug | Neg | 0.41 | p-value | Hyaluronic Acid | |
View | 221 | Human | Clinical | Multiple Organs :: observation :: Pain | Drug | Neg | -124.0 | ||||
View | 221 | Human | Clinical | Multiple Organs :: observation :: Pain | Placebo | Neg | -109.0 | ||||
View | 221 | SMC021 Oral Calcitonin 0.8 mg | Human | Clinical | Bone :: X-ray :: Joint Space Width (JSW) | Drug | Neg | -0.188 | SMC021 | ||
View | 221 | SMC021 Oral Calcitonin 0.8 mg | Human | Clinical | Bone :: X-ray :: Joint Space Width (JSW) | Placebo | Neg | -0.198 | SMC021 | ||
View | 216 | EVEROLIMUS 4.5 mg | Human | Clinical | Vasculature :: observation :: unspecified | Drug | Pos | 34.6 | % | AFINITOR, AFINITOR DISPERZ, CERTICAN, EVEROLIMUS, RAD001, VOTUBIA, ZORTRESS | |
View | 216 | EVEROLIMUS 4.5 mg | Human | Clinical | Vasculature :: observation :: unspecified | Placebo | Neg | 0.0 | % | AFINITOR, AFINITOR DISPERZ, CERTICAN, EVEROLIMUS, RAD001, VOTUBIA, ZORTRESS | |
View | 216 | EVEROLIMUS 4.5 mg | Human | Clinical | Vasculature :: observation :: unspecified | Drug | Pos | 57.7 | % | AFINITOR, AFINITOR DISPERZ, CERTICAN, EVEROLIMUS, RAD001, VOTUBIA, ZORTRESS | |
View | 218 | EVEROLIMUS 4.5 mg | Human | Clinical | Brain :: observation :: Adverse Event | Drug | Pos | 325.0 | count | AFINITOR, AFINITOR DISPERZ, CERTICAN, EVEROLIMUS, RAD001, VOTUBIA, ZORTRESS | |
View | 218 | EVEROLIMUS 4.5 mg | Human | Clinical | Brain :: observation :: Adverse Event | Placebo | Pos | 147.0 | count | AFINITOR, AFINITOR DISPERZ, CERTICAN, EVEROLIMUS, RAD001, VOTUBIA, ZORTRESS | |
View | 222 | ATORVASTATIN 80.0 mg | Human | Clinical | Vasculature :: observation :: unspecified | Drug | Neg | 0.07 | p-value | SID29215408, Atorvastatin, SID124892211, Lipitor, Atorvastatin hemicalcium salt | |
View | 223 | ATORVASTATIN 80.0 mg | Human | Clinical | Multiple Organs :: Clinical Chemistry :: DNA/RNA Assay | Drug | Neg | 0.811 | p-value | SID29215408, Atorvastatin, SID124892211, Lipitor, Atorvastatin hemicalcium salt | |
View | 223 | ATORVASTATIN 80.0 mg | Human | Clinical | Multiple Organs :: Clinical Chemistry :: Protein Assay | Drug | Neg | 0.898 | p-value | SID29215408, Atorvastatin, SID124892211, Lipitor, Atorvastatin hemicalcium salt | |
View | 224 | ACETAMINOPHEN | Human | Clinical | Blood :: PK :: Cmax | Pos | 21.0 | µg/mL | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||
View | 224 | ACETAMINOPHEN | Human | Clinical | Liver :: observation :: DILI | Pos | APAP, SID11112253, Acetaminophen, Infants' Feverall, SID104171293, SID17390068, Acephen, Neopap, Ofirmev, SID56422763, Tylenol, SID11114188, Datril, SID26747171, SID124882135, Injectapap, Phenaphen, Paracetamol | ||||
View | 224 | ACITRETIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.418 | µg/mL | Acitretin, SID26756475, Soriatane, SID49640651, Ro-10-1670-000, SID29216416, Etretin, Ro-101670000 | ||
View | 224 | ACITRETIN | Human | Clinical | Liver :: observation :: DILI | Pos | Acitretin, SID26756475, Soriatane, SID49640651, Ro-10-1670-000, SID29216416, Etretin, Ro-101670000 | ||||
View | 224 | AMIODARONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.55 | µg/mL | AMIODARONE, Amiodarone, CORDARONE, Cordarone, L-3428, Pacerone, SKF 33134-A, AmiodaroneHCl | ||
View | 224 | AMIODARONE | Human | Clinical | Liver :: observation :: DILI | Pos | AMIODARONE, Amiodarone, CORDARONE, Cordarone, L-3428, Pacerone, SKF 33134-A, AmiodaroneHCl | ||||
View | 224 | ASPIRIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.995 | µg/mL | Acetosalic Acid, Acetylsalicylic Acid, SID87798, SID17390036, Measurin, Ecotrin, SID85230910, SID26752858, 8-Hour Bayer, Salicylic Acid Acetate, SID90340586, SID47193676, SID17389202, Aspirin, Bayer Extra Strength, Equi-Prin, SID26747283, SID50105490, Acetylsalicylic acid | ||
View | 224 | ASPIRIN | Human | Clinical | Liver :: observation :: DILI | Neg | Acetosalic Acid, Acetylsalicylic Acid, SID87798, SID17390036, Measurin, Ecotrin, SID85230910, SID26752858, 8-Hour Bayer, Salicylic Acid Acetate, SID90340586, SID47193676, SID17389202, Aspirin, Bayer Extra Strength, Equi-Prin, SID26747283, SID50105490, Acetylsalicylic acid | ||||
View | 224 | ASTEMIZOLE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0005 | µg/mL | SID56422418, SID26751496, Astemizole, GNF-Pf-2461, R-43512, SID26751497, SID124882662, SID11112828, SID104171329, SID26746979, SID144204231, Hismanal, SID124882660, SID855746 | ||
View | 224 | ASTEMIZOLE | Human | Clinical | Liver :: observation :: DILI | Neg | SID56422418, SID26751496, Astemizole, GNF-Pf-2461, R-43512, SID26751497, SID124882662, SID11112828, SID104171329, SID26746979, SID144204231, Hismanal, SID124882660, SID855746 | ||||
View | 224 | ATENOLOL | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.33 | µg/mL | Esatenolol, Unibloc, SID50104387, Tenormin, ICI-66082, SID90340978, SID855957, SID26751696, Atenolol, SID50085956, Ibinolo | ||
View | 224 | ATENOLOL | Human | Clinical | Liver :: observation :: DILI | Neg | Esatenolol, Unibloc, SID50104387, Tenormin, ICI-66082, SID90340978, SID855957, SID26751696, Atenolol, SID50085956, Ibinolo | ||||
View | 224 | AZATHIOPRINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.0 | µg/mL | Azasan, SID90340846, Azathioprine, BW-57-322, Imuran, SID50105468, SID85230906 | ||
View | 224 | AZATHIOPRINE | Human | Clinical | Liver :: observation :: DILI | Pos | Azasan, SID90340846, Azathioprine, BW-57-322, Imuran, SID50105468, SID85230906 | ||||
View | 224 | AZITHROMYCIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.4 | µg/mL | Azasite, Azithromycin, Azithromycin Dihydrate, CP-62993, Sumamed, Sunamed, XZ-450, ZMax, Zithromax | ||
View | 224 | AZITHROMYCIN | Human | Clinical | Liver :: observation :: DILI | Neg | Azasite, Azithromycin, Azithromycin Dihydrate, CP-62993, Sumamed, Sunamed, XZ-450, ZMax, Zithromax | ||||
View | 224 | BACITRACIN | Human | Clinical | Liver :: observation :: DILI | Neg | Baciferm 50, Albac 50, Bacitracin, E700, Baciim, Baci-Rx, Baciguent | ||||
View | 224 | BAMBUTEROL | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.006 | µg/mL | Bambuterol, SID56463628 | ||
View | 224 | BAMBUTEROL | Human | Clinical | Liver :: observation :: DILI | Neg | Bambuterol, SID56463628 | ||||
View | 224 | BUPIVACAINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.067 | µg/mL | Marcaine, SKY-0402, SID160644527, Anekain, Exparel, Bupivacaine, Sensorcaine | ||
View | 224 | BUPIVACAINE | Human | Clinical | Liver :: observation :: DILI | Neg | Marcaine, SKY-0402, SID160644527, Anekain, Exparel, Bupivacaine, Sensorcaine | ||||
View | 224 | BUSPIRONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.00192 | µg/mL | Buspar, SID11110857, SID11112732, SID26751994, SID11113821, Buspirone, SID90340780, SID104171117, BuspironeHCl | ||
View | 224 | BUSPIRONE | Human | Clinical | Liver :: observation :: DILI | Neg | Buspar, SID11110857, SID11112732, SID26751994, SID11113821, Buspirone, SID90340780, SID104171117, BuspironeHCl | ||||
View | 224 | CHLORPROMAZINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.3 | µg/mL | Largactil, SID57287810, Chlorpromazine Phenolphthalinate, SID90340916, Chlorpromazine, SID50104291, Chlorpromazine Hibenzate, Elmarin, Thorazine, Chlorpromazine Tannate, Megaphen, Sonazine, ChlorpromazineHCl | ||
View | 224 | CHLORPROMAZINE | Human | Clinical | Liver :: observation :: DILI | Pos | Largactil, SID57287810, Chlorpromazine Phenolphthalinate, SID90340916, Chlorpromazine, SID50104291, Chlorpromazine Hibenzate, Elmarin, Thorazine, Chlorpromazine Tannate, Megaphen, Sonazine, ChlorpromazineHCl | ||||
View | 224 | CISAPRIDE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.06 | µg/mL | Propulsid, Cisapride, Risamal, R-51619, SID144204250, Acenalin | ||
View | 224 | CISAPRIDE | Human | Clinical | Liver :: observation :: DILI | Neg | Propulsid, Cisapride, Risamal, R-51619, SID144204250, Acenalin | ||||
View | 224 | CLOTRIMAZOLE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.03 | µg/mL | Mycelex-7, Clotrimazole, Gyne-Lotrimin 3, GNF-Pf-3499, Gyne-Lotrimin Combination Pack, Mycelex, Mycelex-7 Combination Pack, SID90340692, Gynix, Trivagizole 3, Gyne-Lotrimin, BAY-5097, Canesten, Gyne-Lotrimin 3 Combination Pack, SID85230973, Mycelex-G | ||
View | 224 | CLOTRIMAZOLE | Human | Clinical | Liver :: observation :: DILI | Neg | Mycelex-7, Clotrimazole, Gyne-Lotrimin 3, GNF-Pf-3499, Gyne-Lotrimin Combination Pack, Mycelex, Mycelex-7 Combination Pack, SID90340692, Gynix, Trivagizole 3, Gyne-Lotrimin, BAY-5097, Canesten, Gyne-Lotrimin 3 Combination Pack, SID85230973, Mycelex-G | ||||
View | 224 | COLCHICINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.00564 | µg/mL | SID67636, SID50113686, Colchicine, SID50113685, Colcrys, SID90340644 | ||
View | 224 | COLCHICINE | Human | Clinical | Liver :: observation :: DILI | Neg | SID67636, SID50113686, Colchicine, SID50113685, Colcrys, SID90340644 | ||||
View | 224 | CYCLOPHOSPHAMIDE | Human | Clinical | Blood :: PK :: Cmax | Pos | 69.0 | µg/mL | SID90341534, SID87150, Cyclophosphamide, Neosar, SID85230959, SID50105634, Sendoxan, Cytoxan | ||
View | 224 | CYCLOPHOSPHAMIDE | Human | Clinical | Liver :: observation :: DILI | Pos | SID90341534, SID87150, Cyclophosphamide, Neosar, SID85230959, SID50105634, Sendoxan, Cytoxan | ||||
View | 224 | DEFEROXAMINE MESYLATE | Human | Clinical | Blood :: PK :: Cmax | Pos | 10.0 | µg/mL | Desferrioxamine Mesylate, Deferoxamine Mesylate, Desferal Mesylate, SID11112937, SID11533050, SID124882730, Desferal, SID26747967, Desferrioxamine Mesilate, BA-33112, Deferoxamine Mesilate, DFO | ||
View | 224 | DEFEROXAMINE MESYLATE | Human | Clinical | Liver :: observation :: DILI | Pos | Desferrioxamine Mesylate, Deferoxamine Mesylate, Desferal Mesylate, SID11112937, SID11533050, SID124882730, Desferal, SID26747967, Desferrioxamine Mesilate, BA-33112, Deferoxamine Mesilate, DFO | ||||
View | 224 | DESIPRAMINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0168 | µg/mL | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | ||
View | 224 | DESIPRAMINE | Human | Clinical | Liver :: observation :: DILI | Neg | Desipramine, Pertofrane, SID50104283, SID50100220, SID90341801, SID11111067, Norpramin, SID11111066 | ||||
View | 224 | DEXAMETHASONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.088 | µg/mL | Decadron, Dexacen-4, Dexone 4, Kortico Injection, Aeroseb-Dex, Decaspray, Dexamethasone Palmitate, Maxidex, Mymethasone, Ozurdex, Dexair, Dexamethasone Intensol, Dexamethasone Metasulfobenzoate Sodium, Dexamethasone Valerate, SID26752876, Dalalone, Dexamethasone, Dexone, Dexone 0.75, Dexone 1.5, Fluormethylprednisolone, Decaderm, Decadron-LA, Dexacort, Hexadrol, SID17389945, Dexone 0.5, Neodecadron | ||
View | 224 | DEXAMETHASONE | Human | Clinical | Liver :: observation :: DILI | Neg | Decadron, Dexacen-4, Dexone 4, Kortico Injection, Aeroseb-Dex, Decaspray, Dexamethasone Palmitate, Maxidex, Mymethasone, Ozurdex, Dexair, Dexamethasone Intensol, Dexamethasone Metasulfobenzoate Sodium, Dexamethasone Valerate, SID26752876, Dalalone, Dexamethasone, Dexone, Dexone 0.75, Dexone 1.5, Fluormethylprednisolone, Decaderm, Decadron-LA, Dexacort, Hexadrol, SID17389945, Dexone 0.5, Neodecadron | ||||
View | 224 | DICLOFENAC | Human | Clinical | Blood :: PK :: Cmax | Pos | 2.367 | µg/mL | SID24424557, Arthrotec, Diclofenac, Voltaren-XR, Cataflam, Solaraze, Voltaren, Voltaren Xr, Voltaren Ophthalmic, Cambia, DiclofenacNa | ||
View | 224 | DICLOFENAC | Human | Clinical | Liver :: observation :: DILI | Pos | SID24424557, Arthrotec, Diclofenac, Voltaren-XR, Cataflam, Solaraze, Voltaren, Voltaren Xr, Voltaren Ophthalmic, Cambia, DiclofenacNa | ||||
View | 224 | DIDANOSINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.922 | µg/mL | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | ||
View | 224 | DIDANOSINE | Human | Clinical | Liver :: observation :: DILI | Pos | BMY-40900, SID29215491, SID17389541, SID26754510, SID26719672, Videx, DDI, SID26757698, Didanosine, Videx Ec, Dideoxyinosine (DDI), SID49718183 | ||||
View | 224 | DIGOXIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.00221 | µg/mL | DIGOXIN, Digoxin, Digoxin pediatric, LANOXIN, Lanoxicaps, Lanoxin, Lanoxin pediatric, Vanoxin | ||
View | 224 | DIGOXIN | Human | Clinical | Liver :: observation :: DILI | Neg | DIGOXIN, Digoxin, Digoxin pediatric, LANOXIN, Lanoxicaps, Lanoxin, Lanoxin pediatric, Vanoxin | ||||
View | 224 | ERYTHROMYCIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.33 | µg/mL | C-Solve-2, E-Solve 2, Erythra-Derm, Ilotycin, Pce, E-Base, E-Mycin, PCE, Pfizer-E, Benzamycin, Eryc 125, Erythro 200, Staticin, Ery-Tab, Bristamycin, Emgel, Eryc Sprinkles, Erycette, Erymax, Gallimycin, A/T/S, E-Glades, ERY-TAB, Eryderm, Erythrocin, R-P Mycin, Wyamycin, Akne-Mycin, Erypar, Erythro-Statin, Erythromycin, ERYC, Erygel, Robimycin, Sansac, T-Stat | ||
View | 224 | ERYTHROMYCIN | Human | Clinical | Liver :: observation :: DILI | Neg | C-Solve-2, E-Solve 2, Erythra-Derm, Ilotycin, Pce, E-Base, E-Mycin, PCE, Pfizer-E, Benzamycin, Eryc 125, Erythro 200, Staticin, Ery-Tab, Bristamycin, Emgel, Eryc Sprinkles, Erycette, Erymax, Gallimycin, A/T/S, E-Glades, ERY-TAB, Eryderm, Erythrocin, R-P Mycin, Wyamycin, Akne-Mycin, Erypar, Erythro-Statin, Erythromycin, ERYC, Erygel, Robimycin, Sansac, T-Stat | ||||
View | 224 | ESTRADIOL | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0000429 | µg/mL | AGOFOLLIN, ALORA, Alfatradiol, Aquagen, CLIMARA, Climara Pro, DESTRADIOL, DIHYDROTHEELIN, DIHYDROXYESTRIN, Depo-Estradiol, Divigel, E-Cypionate, ELESTRIM, ESTRACE, ESTRADERM, ESTRADIOL, ESTRADIOL HEMIHYDRATE, ESTRING, ESTROGEL, Elestrin, Esclim, Estradiol, Estradiol hemihydrate, Estrasorb, Evamist, FEMPATCH, GVNODIOL, GYNERGON, GYNOESTRYL, Gynodiol, Gynogen, INNOFEM, MENOSTAR, MINIVELLE, OESTRADIOL, Oestradiol, VAGIFEM, VIVELLE, Vagifem 18, Vagifem 8, Vivelle-Dot | ||
View | 224 | ESTRADIOL | Human | Clinical | Liver :: observation :: DILI | Neg | AGOFOLLIN, ALORA, Alfatradiol, Aquagen, CLIMARA, Climara Pro, DESTRADIOL, DIHYDROTHEELIN, DIHYDROXYESTRIN, Depo-Estradiol, Divigel, E-Cypionate, ELESTRIM, ESTRACE, ESTRADERM, ESTRADIOL, ESTRADIOL HEMIHYDRATE, ESTRING, ESTROGEL, Elestrin, Esclim, Estradiol, Estradiol hemihydrate, Estrasorb, Evamist, FEMPATCH, GVNODIOL, GYNERGON, GYNOESTRYL, Gynodiol, Gynogen, INNOFEM, MENOSTAR, MINIVELLE, OESTRADIOL, Oestradiol, VAGIFEM, VIVELLE, Vagifem 18, Vagifem 8, Vivelle-Dot | ||||
View | 224 | PYRIMETHAMINE | Human | Clinical | Liver :: observation :: DILI | Pos | SID50100376, Pyrimethamine, Daraprim, Malacide, SID50104113, GNF-Pf-5586, Chloridin, TCMDC-123831, TCMDC-125860 | ||||
View | 224 | CAPTOPRIL | Human | Clinical | Liver :: observation :: DILI | Pos | CAPOTEN, CAPTOPRIL, Capoten, Captopril, Lopril, SQ 14,225, SQ-14225, Tensobon | ||||
View | 224 | ESTRONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0059 | µg/mL | Estrogenic Substance, Estrone, Oestrone, Theelin | ||
View | 224 | ESTRONE | Human | Clinical | Liver :: observation :: DILI | Pos | Estrogenic Substance, Estrone, Oestrone, Theelin | ||||
View | 224 | FAMOTIDINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.104 | µg/mL | Pepcid Rpd, SID85231052, SID144203704, SID26753575, Fluxid, SID11111194, Pepcid, SID50106279, SID26748463, SID11111195, MK-208, SID49681730, SID855518, Famotidine, Pepcid Ac | ||
View | 224 | FAMOTIDINE | Human | Clinical | Liver :: observation :: DILI | Neg | Pepcid Rpd, SID85231052, SID144203704, SID26753575, Fluxid, SID11111194, Pepcid, SID50106279, SID26748463, SID11111195, MK-208, SID49681730, SID855518, Famotidine, Pepcid Ac | ||||
View | 224 | FELBAMATE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0196 | µg/mL | SID855835, SID11113343, SID56422162, Felbamate, Felbatol, W-554, SID50104096, SID144203696, SID90340922 | ||
View | 224 | FELBAMATE | Human | Clinical | Liver :: observation :: DILI | Pos | SID855835, SID11113343, SID56422162, Felbamate, Felbatol, W-554, SID50104096, SID144203696, SID90340922 | ||||
View | 224 | FENOFIBRATE | Human | Clinical | Blood :: PK :: Cmax | Pos | 4.38 | µg/mL | Fenofibrate, Antara, Lipidil, Fenoglide, Tricor, Triglide, Lipofen | ||
View | 224 | FENOFIBRATE | Human | Clinical | Liver :: observation :: DILI | Pos | Fenofibrate, Antara, Lipidil, Fenoglide, Tricor, Triglide, Lipofen | ||||
View | 224 | FLUOXETINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.015 | µg/mL | Prozac, Sarafem, Symbyax, SID104171153, SID26755310, SID26751973, SID50104648, Fluoxetine, SID90341619, SID144203695, Prozac Weekly, FluoxetineHCl | ||
View | 224 | FLUOXETINE | Human | Clinical | Liver :: observation :: DILI | Neg | Prozac, Sarafem, Symbyax, SID104171153, SID26755310, SID26751973, SID50104648, Fluoxetine, SID90341619, SID144203695, Prozac Weekly, FluoxetineHCl | ||||
View | 224 | FLUTAMIDE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.1 | µg/mL | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | ||
View | 224 | FLUTAMIDE | Human | Clinical | Liver :: observation :: DILI | Pos | SID26753015, SID104171162, SID17388997, SID26747366, SID144203705, Flutamide, SCH-13521, SID85231055, SID11532925, SID90341271, Drogenil, SID50105597, SID124880151, SID50105599, SID26747365, SID50105598, SID49675006, Eulexin, SID26753014, SID11111203, SID11111202, SID124880153, SID50105600 | ||||
View | 224 | FLUVASTATIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.273 | µg/mL | Fluvastatin | ||
View | 224 | FLUVASTATIN | Human | Clinical | Liver :: observation :: DILI | Neg | Fluvastatin | ||||
View | 224 | FUROSEMIDE | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.08 | µg/mL | Aquamed, Disal, FRUSEMIDE, FUROSEMIDE, Frusemide, Furosemide, LASIX, LB-502 | ||
View | 224 | FUROSEMIDE | Human | Clinical | Liver :: observation :: DILI | Pos | Aquamed, Disal, FRUSEMIDE, FUROSEMIDE, Frusemide, Furosemide, LASIX, LB-502 | ||||
View | 224 | GABAPENTIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 2.474 | µg/mL | SID90340599, SID50103936, SID11112806, SID11113327, SID104171164, Gabapentin, Neurontin, SID855579, CI-945, GOE-3450, Gralise | ||
View | 224 | GABAPENTIN | Human | Clinical | Liver :: observation :: DILI | Neg | SID90340599, SID50103936, SID11112806, SID11113327, SID104171164, Gabapentin, Neurontin, SID855579, CI-945, GOE-3450, Gralise | ||||
View | 224 | GLAFENINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.7 | µg/mL | Glycerylaminophenaquine, Glaphenine, R-1707, Glafenine, SID26748455 | ||
View | 224 | GLAFENINE | Human | Clinical | Liver :: observation :: DILI | Pos | Glycerylaminophenaquine, Glaphenine, R-1707, Glafenine, SID26748455 | ||||
View | 224 | GLIMEPIRIDE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.551 | µg/mL | SID49648856, HOE-490, Glimepiride, Amaryl | ||
View | 224 | GLIMEPIRIDE | Human | Clinical | Liver :: observation :: DILI | Neg | SID49648856, HOE-490, Glimepiride, Amaryl | ||||
View | 224 | INDOMETHACIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 2.0 | µg/mL | SID90340917, Indocin, Indometacin, Indomethacin, Desmethyl indomethacin, SID856012, Indocin SR, Indo-Lemmon, Indometacin Farnesil, SID85231093, SID56422212 | ||
View | 224 | INDOMETHACIN | Human | Clinical | Liver :: observation :: DILI | Pos | SID90340917, Indocin, Indometacin, Indomethacin, Desmethyl indomethacin, SID856012, Indocin SR, Indo-Lemmon, Indometacin Farnesil, SID85231093, SID56422212 | ||||
View | 224 | ISONIAZID | Human | Clinical | Blood :: PK :: Cmax | Pos | 10.5 | µg/mL | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | ||
View | 224 | ISONIAZID | Human | Clinical | Liver :: observation :: DILI | Pos | SID26746988, SID121269825, Dow-Isoniazid, Nydrazid, SID49718175, Isonicotinylhydrazine, Laniazid, Rimifon, SID11112128, SID26751504, Hyzyd, Isoniazid, SID17389848, SID124881933, Stanozide, INH, SID855769, Isoniazide | ||||
View | 224 | ISOTRETINOIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.301 | µg/mL | Ro-43780, Absorica, Isotretinoin, SID90341473, Accutane, Myorisan, SID47193696, SID50106981, Sotret, 13 Cis-Retinoic Acid, Claravis, Amnesteem | ||
View | 224 | ISOTRETINOIN | Human | Clinical | Liver :: observation :: DILI | Pos | Ro-43780, Absorica, Isotretinoin, SID90341473, Accutane, Myorisan, SID47193696, SID50106981, Sotret, 13 Cis-Retinoic Acid, Claravis, Amnesteem | ||||
View | 224 | L-ARGININE | Human | Clinical | Liver :: observation :: DILI | Neg | SID50104526, Arginine, SID11113629, SID90341198, R-Gene, SID11110746 | ||||
View | 224 | LEVODOPA | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.35 | µg/mL | levodopa, L-dopa, Dopar, 3,4-dihydroxy-L-phenylalanine, 59-92-7, 3-Hydroxy-L-tyrosine, Bendopa, Dopasol, Larodopa, Levopa, Cidandopa, Dopaidan, Dopalina, Insulamina, Maipedopa, Eldopal, Eldopar, Pardopa, Prodopa, Syndopa, Helfo-Dopa, Dopaflex, Dopaston, Doparl, (-)-Dopa, Dihydroxy-L-phenylalanine, 3-(3,4-Dihydroxyphenyl)-L-alanine, 3,4-Dihydroxyphenylalanine, Brocadopa, Doparkine, Dopastral, Eldopatec, Eurodopa, Levedopa, Deadopa, Doprin, Veldopa, Dopal-fher, Ledopa, Dopal, Weldopa, Parda, L-o-Hydroxytyrosine, Dopa, 3,4-Dihydroxyphenyl-L-alanine, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, L-Dihydroxyphenylalanine, Laradopa, Levodopum, (-)-3-(3,4-Dihydroxyphenyl)-L-alanine, L-3-Hydroxytyrosine, L-Tyrosine 3-hydroxy-, L-(-)-Dopa, Dopaston SE, L-(o-Dihydroxyphenyl)alanine, L-3,4-Dihydroxyphenylalanine, L-beta-(3,4-Dihydroxyphenyl)alanine, Biodopa, Cerepap, Sobiodopa, beta-(3,4-Dihydroxyphenyl)-L-alanine, beta-(3,4-Dihydroxyphenyl)alanine, L-3-(3,4-Dihydroxyphenyl)alanine, Helfo DOPA, L Dopa, Ro 4-6316, component of Sinemet, Dopar (TN), Tyrosine 3-hydroxy-, Dopastone, Dopicar, Levodopum [INN-Latin], CHEBI:15765, L(-)-Dopa, IV Levodopa, L-O-Dihydroxyphenylalanine, alanine 3-(3,4-dihydroxyphenyl)-, L-, (-)-(3,4-Dihydroxyphenyl)alanine, beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine, L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine, CHEMBL1009, Prestwick_185, CCRIS 3766, L-.beta.-(3,4-Dihydroxyphenyl)alanine, .beta.-(3,4-Dihydroxyphenyl)-L-alanine, S1726_Selleck, HSDB 3348, Spectrum_000454, UNII-46627O600J, 3,4-Dihydroxyphenylalanine (VAN), Alanine 3-(3,4-dihydroxyphenyl)-, (-)-, AC1L1LOR, Prestwick0_000017, Prestwick1_000017, Prestwick2_000017, Prestwick3_000017, Spectrum2_000496, Spectrum4_000539, Spectrum5_001899, EINECS 200-445-2, Lopac-D-9628, dihydroxyphenylalanine, Levodopa (JP15/USP), NSC118381, bmse000322, NSC 118381, AC1Q4U7F, (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, CAS-59-92-7, 3 4-Dihydroxyphenylalanine, Lopac0_000454, BSPBio_000053, BSPBio_002354, KBioGR_001177, KBioSS_000934, L-4-5-Dihydroxyphenylalanine, beta-(3,4-Dihydroxyphenyl)-alpha-alanine, BIDD:GT0158, Bio-0575, D9628_SIGMA, DivK1c_000452, SPBio_000391, SPBio_001974, SPECTRUM2300205, MLS000028514, BPBio1_000059, b-(3,4-Dihydroxyphenyl)alanine, 3 4-Dihydroxy-L-phenylalanine, 37830_FLUKA, HMS501G14, KBio1_000452, KBio2_000934, KBio2_003502, KBio2_006070, L-(3,4-Dihydroxyphenyl)alanine, Levodopa [USAN:INN:BAN:JAN], NINDS_000452, L-(3 4-Dihydroxyphenyl)alanine, WTDRDQBEARUVNC-LURJTMIESA-N, HMS1568C15, HMS1922J14, HMS2090O08, HMS2093N04, b-(3,4-Dihydroxyphenyl)-L-alanine, L-3-(3,4-dihydroxyphenyl)-Alanine, Alanine 3-(3,4-dihydroxyphenyl)-, LS-255, MFCD00002598, PDSP1_001541, PDSP2_001525, .beta.-(3,4-Dihydroxyphenyl)alanine, C9H11NO4, b-(3,4-Dihydroxyphenyl)-a-L-alanine, L-b-(3,4-Dihydroxyphenyl)-a-alanine, .beta.-(3 4-Dihydroxyphenyl)alanine, DB01235, SDCCGMLS-0066924.P001, IDI1_000452, NCGC00015384-01, NCGC00016270-01, NCGC00016270-04, NCGC00016270-06, NCGC00093869-04, SMR000058312, L-(3,4-Dihydroxyphenyl)-.alpha.-alanine, D0600, D9628, EU-0100454, Alanine 3-(3, 4-dihydroxyphenyl)-, (-)-, C00355, D 9628, D00059, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate, 587-45-1, DAH, 1E83F927-C221-46AA-B90A-81B33C5F3868, 23734-74-9, 25525-15-9, 34241-25-3, 72572-99-7, 72573-00-3, 88250-23-1, 90638-38-3, L-DOPA Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa, L-3,4-Dihydrophenylalanine, WLN: QVYZ1R CQ DQ, Sinemetreg, Bidopal, CID6047, l)-L-alanine, L-DOPA; Levodopa, Madopa (Salt/Mix), nchembio.89-comp9, 3-(3,4-Dihydroxypheny, DSSTox_CID_3209, Epitope ID:150927, Alanine,4-dihydroxyphenyl)-, DSSTox_RID_76926, DSSTox_GSID_23209, SCHEMBL22655, L-Dopa L-3-Hydroxytyrosine, Levodopa (JP15/USP/INN), Levodopa (JP17/USP/INN), nchembio.2007.55-comp26, GTPL3639, (S)-3,4-dihydroxyphenylalanine, DTXSID9023209, WLN: QVYZ1R CQ DQ -L, CTK1H2187, HMDB00181, Alanine,4-dihydroxyphenyl)- L-, HMS2095C15, HMS2230B04, HMS3261K10, Pharmakon1600-0230020 | ||
View | 224 | LEVODOPA | Human | Clinical | Liver :: observation :: DILI | Neg | levodopa, L-dopa, Dopar, 3,4-dihydroxy-L-phenylalanine, 59-92-7, 3-Hydroxy-L-tyrosine, Bendopa, Dopasol, Larodopa, Levopa, Cidandopa, Dopaidan, Dopalina, Insulamina, Maipedopa, Eldopal, Eldopar, Pardopa, Prodopa, Syndopa, Helfo-Dopa, Dopaflex, Dopaston, Doparl, (-)-Dopa, Dihydroxy-L-phenylalanine, 3-(3,4-Dihydroxyphenyl)-L-alanine, 3,4-Dihydroxyphenylalanine, Brocadopa, Doparkine, Dopastral, Eldopatec, Eurodopa, Levedopa, Deadopa, Doprin, Veldopa, Dopal-fher, Ledopa, Dopal, Weldopa, Parda, L-o-Hydroxytyrosine, Dopa, 3,4-Dihydroxyphenyl-L-alanine, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, L-Dihydroxyphenylalanine, Laradopa, Levodopum, (-)-3-(3,4-Dihydroxyphenyl)-L-alanine, L-3-Hydroxytyrosine, L-Tyrosine 3-hydroxy-, L-(-)-Dopa, Dopaston SE, L-(o-Dihydroxyphenyl)alanine, L-3,4-Dihydroxyphenylalanine, L-beta-(3,4-Dihydroxyphenyl)alanine, Biodopa, Cerepap, Sobiodopa, beta-(3,4-Dihydroxyphenyl)-L-alanine, beta-(3,4-Dihydroxyphenyl)alanine, L-3-(3,4-Dihydroxyphenyl)alanine, Helfo DOPA, L Dopa, Ro 4-6316, component of Sinemet, Dopar (TN), Tyrosine 3-hydroxy-, Dopastone, Dopicar, Levodopum [INN-Latin], CHEBI:15765, L(-)-Dopa, IV Levodopa, L-O-Dihydroxyphenylalanine, alanine 3-(3,4-dihydroxyphenyl)-, L-, (-)-(3,4-Dihydroxyphenyl)alanine, beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine, L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine, CHEMBL1009, Prestwick_185, CCRIS 3766, L-.beta.-(3,4-Dihydroxyphenyl)alanine, .beta.-(3,4-Dihydroxyphenyl)-L-alanine, S1726_Selleck, HSDB 3348, Spectrum_000454, UNII-46627O600J, 3,4-Dihydroxyphenylalanine (VAN), Alanine 3-(3,4-dihydroxyphenyl)-, (-)-, AC1L1LOR, Prestwick0_000017, Prestwick1_000017, Prestwick2_000017, Prestwick3_000017, Spectrum2_000496, Spectrum4_000539, Spectrum5_001899, EINECS 200-445-2, Lopac-D-9628, dihydroxyphenylalanine, Levodopa (JP15/USP), NSC118381, bmse000322, NSC 118381, AC1Q4U7F, (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, CAS-59-92-7, 3 4-Dihydroxyphenylalanine, Lopac0_000454, BSPBio_000053, BSPBio_002354, KBioGR_001177, KBioSS_000934, L-4-5-Dihydroxyphenylalanine, beta-(3,4-Dihydroxyphenyl)-alpha-alanine, BIDD:GT0158, Bio-0575, D9628_SIGMA, DivK1c_000452, SPBio_000391, SPBio_001974, SPECTRUM2300205, MLS000028514, BPBio1_000059, b-(3,4-Dihydroxyphenyl)alanine, 3 4-Dihydroxy-L-phenylalanine, 37830_FLUKA, HMS501G14, KBio1_000452, KBio2_000934, KBio2_003502, KBio2_006070, L-(3,4-Dihydroxyphenyl)alanine, Levodopa [USAN:INN:BAN:JAN], NINDS_000452, L-(3 4-Dihydroxyphenyl)alanine, WTDRDQBEARUVNC-LURJTMIESA-N, HMS1568C15, HMS1922J14, HMS2090O08, HMS2093N04, b-(3,4-Dihydroxyphenyl)-L-alanine, L-3-(3,4-dihydroxyphenyl)-Alanine, Alanine 3-(3,4-dihydroxyphenyl)-, LS-255, MFCD00002598, PDSP1_001541, PDSP2_001525, .beta.-(3,4-Dihydroxyphenyl)alanine, C9H11NO4, b-(3,4-Dihydroxyphenyl)-a-L-alanine, L-b-(3,4-Dihydroxyphenyl)-a-alanine, .beta.-(3 4-Dihydroxyphenyl)alanine, DB01235, SDCCGMLS-0066924.P001, IDI1_000452, NCGC00015384-01, NCGC00016270-01, NCGC00016270-04, NCGC00016270-06, NCGC00093869-04, SMR000058312, L-(3,4-Dihydroxyphenyl)-.alpha.-alanine, D0600, D9628, EU-0100454, Alanine 3-(3, 4-dihydroxyphenyl)-, (-)-, C00355, D 9628, D00059, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate, 587-45-1, DAH, 1E83F927-C221-46AA-B90A-81B33C5F3868, 23734-74-9, 25525-15-9, 34241-25-3, 72572-99-7, 72573-00-3, 88250-23-1, 90638-38-3, L-DOPA Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa, L-3,4-Dihydrophenylalanine, WLN: QVYZ1R CQ DQ, Sinemetreg, Bidopal, CID6047, l)-L-alanine, L-DOPA; Levodopa, Madopa (Salt/Mix), nchembio.89-comp9, 3-(3,4-Dihydroxypheny, DSSTox_CID_3209, Epitope ID:150927, Alanine,4-dihydroxyphenyl)-, DSSTox_RID_76926, DSSTox_GSID_23209, SCHEMBL22655, L-Dopa L-3-Hydroxytyrosine, Levodopa (JP15/USP/INN), Levodopa (JP17/USP/INN), nchembio.2007.55-comp26, GTPL3639, (S)-3,4-dihydroxyphenylalanine, DTXSID9023209, WLN: QVYZ1R CQ DQ -L, CTK1H2187, HMDB00181, Alanine,4-dihydroxyphenyl)- L-, HMS2095C15, HMS2230B04, HMS3261K10, Pharmakon1600-0230020 | ||||
View | 224 | LEVOFLOXACIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 5.7 | µg/mL | Levofloxacin, Iquix, RWJ-25213, DR-3355, Levaquin, Quixin, SID49665952, Floxacin, SID26719895 | ||
View | 224 | LEVOFLOXACIN | Human | Clinical | Liver :: observation :: DILI | Neg | Levofloxacin, Iquix, RWJ-25213, DR-3355, Levaquin, Quixin, SID49665952, Floxacin, SID26719895 | ||||
View | 224 | LIDOCAINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 8.5 | µg/mL | Xylocaine, Lignocaine Hcl, Anestacon, SID56422194, Iontocaine, Octocaine, SID26751484, Alphacaine, Lidopen, SID104171182, SID11111385, SID855682, Lignocaine, SID26751483, Dentipatch, Embolex, Lidocaton, Lidoderm, Lidocaine, Terramycin, Lignostab, LMX, SID90340642, SID11111384 | ||
View | 224 | LIDOCAINE | Human | Clinical | Liver :: observation :: DILI | Neg | Xylocaine, Lignocaine Hcl, Anestacon, SID56422194, Iontocaine, Octocaine, SID26751484, Alphacaine, Lidopen, SID104171182, SID11111385, SID855682, Lignocaine, SID26751483, Dentipatch, Embolex, Lidocaton, Lidoderm, Lidocaine, Terramycin, Lignostab, LMX, SID90340642, SID11111384 | ||||
View | 224 | LISINOPRIL | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.29 | µg/mL | LISINOPRIL, MK-521, Lisinopril Dihydrate | ||
View | 224 | LISINOPRIL | Human | Clinical | Liver :: observation :: DILI | Pos | LISINOPRIL, MK-521, Lisinopril Dihydrate | ||||
View | 224 | LOVASTATIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.01 | µg/mL | SID17389841, SID26751557, Altoprev, SID49732779, SID855905, Lovastatin, SID496591, MK-803, Mevacor, Mevinolin, SID144204439 | ||
View | 224 | LOVASTATIN | Human | Clinical | Liver :: observation :: DILI | Neg | SID17389841, SID26751557, Altoprev, SID49732779, SID855905, Lovastatin, SID496591, MK-803, Mevacor, Mevinolin, SID144204439 | ||||
View | 224 | MALEIC ACID | Human | Clinical | Liver :: observation :: DILI | Pos | maleic acid, cis-butenedioic acid, Toxilic acid, 110-16-7, Maleinic acid, Malenic acid, maleate, (Z)-Butenedioic acid, 2-Butenedioic acid (Z)-, Kyselina maleinova, (2Z)-but-2-enedioic acid, cis-1,2-Ethylenedicarboxylic acid, (Z)-2-Butenedioic acid, 2-Butenedioic acid (2Z)-, 2-Butenedioic acid, cis-2-Butenedioic acid, Malezid CM, Butenedioic acid, (Z)-, 2-Butenedioic acid, (Z)-, Cis-butenedioate, 2-Butenedioate, (z)-butenedioate, H2male, 1,2-Ethylenedicarboxylic acid, (Z), cis-2-Butenedioate, cis-but-2-enedioate, Scotchbond Multipurpose Etchant, Sodium maleate, CCRIS 1115, HSDB 666, (2Z)-2-Butenedioate, cis-but-2-enedioic acid, (2Z)-but-2-enedioate, (2Z)-Butene-2-dioate, But-2-enedioic acid, (2Z)-2-Butenedioic acid, Kyselina maleinova [Czech], Maleic acid [NA2215], (Z)-2-Butenedioate, (2Z)-Butene-2-dioic acid, UNII-91XW058U2C, AI3-01002, CHEBI:18300, VZCYOOQTPOCHFL-UPHRSURJSA-N, EINECS 203-742-5, Maleic acid [NA2215] [Corrosive], MFCD00063177, NA2215, NSC 25940, SBB040567, MAE, BRN 0605762, DSSTox_CID_1517, (2Z)but-2-enedioic acid, (Z)-but-2-enedioic acid, DSSTox_RID_76194, DSSTox_GSID_21517, CAS-110-16-7, C4H4O4, Acidum maleicum, 1ahy, 1tok, L-Maleic Acid, NCGC00091192-02, bis-hydrogen maleate, MALEICACID, Maleic acid (8CI), PubChem21784, Butenedioic acid,(Z)-, SCHEMBL613, bmse000212, WLN: QV1U1VQ-C, AC1L9G1A, MLS002153468, 2-butenedioic acid, (2Z)-, (2Z)-2-Butenedioic acid #, AC1Q71E5, CHEMBL539648, M0375_SIAL, DTXSID8021517, 63189_FLUKA, HMDB00176, InChI=1/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1, 91XW058U2C, HMS2236F09, cis-Butenedioic acid; Toxilic acid, 2-Butenedioic acid (Z)- (9CI), 6915-18-0, NSC25940, STR03481, 10237-70-4 (potassium salt), Tox21_113105, Tox21_202193, Tox21_303045, 1,2-Ethylenedicarboxylic acid, cis-, 2-Butenedioic acid (2Z)- (9CI), 37449-49-3 (Nd salt), LS-499, NSC-25940, ZINC12358683, 371-47-1 (di-hydrochloride salt), 18016-19-8 (hydrochloride salt), AKOS000268822, Tox21_113105_1, 44742-89-4 (mono-ammonium salt), Maleic acid [NA2215] [Corrosive], RP19212, 3105-55-3 (mono-hydrochloride salt), Maleic anhydride, mono(castor oil) ester, NCGC00090970-01, NCGC00090970-02, NCGC00090970-03, NCGC00257215-01, NCGC00259742-01, 4CN-0931, AK109350, AN-22588, BT000111, KB-53311, OR036502, OR180703, OR194615, OR271441, SMR001230824, AB1009478, 102-EP2269610A2, 102-EP2269983A1, 102-EP2269984A1, 102-EP2269988A2, 102-EP2269989A1, 102-EP2269990A1, 102-EP2270002A1, 102-EP2270003A1, 102-EP2270006A1, 102-EP2270008A1, 102-EP2270011A1, 102-EP2270505A1, 102-EP2272537A2, 102-EP2272822A1, 102-EP2272827A1, 102-EP2272834A1, 102-EP2272849A1, 102-EP2275401A1, 102-EP2275411A2, 102-EP2275412A1, 102-EP2275413A1, 102-EP2275414A1, 102-EP2277507A1, 102-EP2277848A1, 102-EP2277858A1, 102-EP2277866A1, 102-EP2277867A2, 102-EP2280003A2, 102-EP2280006A1, 102-EP2280009A1, 102-EP2280010A2, 102-EP2280012A2, 102-EP2281559A1, 102-EP2281563A1, 102-EP2281819A1, 102-EP2281823A2, 102-EP2284149A1, 102-EP2284160A1, 102-EP2284169A1, 102-EP2284178A2, 102-EP2284179A2, 102-EP2286795A1, 102-EP2287147A2, 102-EP2287153A1, 102-EP2287155A1, 102-EP2287156A1, 102-EP2287160A1, 102-EP2287161A1, 102-EP2287162A1, 102-EP2289510A1, 102-EP2289518A1, 102-EP2289879A1, 102-EP2289883A1, 102-EP2289890A1, 102-EP2289894A2, 102-EP2292227A2, 102-EP2292228A1, 102-EP2292231A1, 102-EP2292234A1, 102-EP2292592A1, 102-EP2292611A1, 102-EP2292615A1, 102-EP2292617A1, 102-EP2292619A1, 102-EP2295401A2, 102-EP2295402A2, 102-EP2295406A1, 102-EP2295415A1, 102-EP2295416A2, 102-EP2295418A1, 102-EP2295424A1, 102-EP2295426A1, 102-EP2295427A1, 102-EP2295433A2, 102-EP2295437A1, 102-EP2298731A1, 102-EP2298734A2, 102-EP2298735A1, 102-EP2298746A1, 102-EP2298747A1, 102-EP2298748A2, 102-EP2298755A1, 102-EP2298757A2, 102-EP2298758A1, 102-EP2298759A1, 102-EP2298767A1, 102-EP2298772A1, 102-EP2298775A1, 102-EP2298779A1, 102-EP2301544A1, 102-EP2301922A1, 102-EP2301923A1, 102-EP2301924A1, 102-EP2301928A1, 102-EP2301929A1, 102-EP2301931A1, 102-EP2301933A1, 102-EP2301935A1, 102-EP2301937A1, 102-EP230194 | ||||
View | 224 | METHOTREXATE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.351 | µg/mL | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | ||
View | 224 | METHOTREXATE | Human | Clinical | Liver :: observation :: DILI | Pos | TCMDC-125858, TCMDC-125488, SID50104778, SID124886991, Trexall, CL-14377, SID90340825, SID11113978, Mexate, SID26752122, SID144204495, Methylaminopterin, SID50104777, SID56463665, SID26752121, Amethopterin, TCMDC-123832, SID67627, SID26752120, Methotrexate, Abitrexate, Folex, Mexate-AQ, Rheumatrex | ||||
View | 224 | MICONAZOLE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.01 | µg/mL | Monistat-3, SID443253, Vusion, Micatin, Monistat, Conofite, Oravig, Monistat-Derm, SID144204152, SID85148356, Miconazole, Dermazole | ||
View | 224 | MICONAZOLE | Human | Clinical | Liver :: observation :: DILI | Neg | Monistat-3, SID443253, Vusion, Micatin, Monistat, Conofite, Oravig, Monistat-Derm, SID144204152, SID85148356, Miconazole, Dermazole | ||||
View | 224 | MONTELUKAST | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.38 | µg/mL | MK-476, Singulair, Montelukast, Montelo-10 | ||
View | 224 | MONTELUKAST | Human | Clinical | Liver :: observation :: DILI | Neg | MK-476, Singulair, Montelukast, Montelo-10 | ||||
View | 224 | NADOLOL | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.13 | µg/mL | Nadolol, SQ-11725, SID855594, SID56422422, Corgard | ||
View | 224 | NADOLOL | Human | Clinical | Liver :: observation :: DILI | Neg | Nadolol, SQ-11725, SID855594, SID56422422, Corgard | ||||
View | 224 | NALTREXONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.02 | µg/mL | Celupan, EN-1639A, Revia, Naltrexone, EN-1639A [As Hydrochloride], Vivitrol, Trexal, Trexan | ||
View | 224 | NALTREXONE | Human | Clinical | Liver :: observation :: DILI | Pos | Celupan, EN-1639A, Revia, Naltrexone, EN-1639A [As Hydrochloride], Vivitrol, Trexal, Trexan | ||||
View | 224 | NEFAZODONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.4349 | µg/mL | Nefazodone, Serzone, SID50111710, SID49666410, Nefadar, Nefazodone Hydrochloride | ||
View | 224 | NEFAZODONE | Human | Clinical | Liver :: observation :: DILI | Pos | Nefazodone, Serzone, SID50111710, SID49666410, Nefadar, Nefazodone Hydrochloride | ||||
View | 224 | NIACIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 18.0 | µg/mL | NIACIN, NIACOR, NIASPAN, NIASPAN TITRATION STARTER PACK, NICANGIN, NICOLAR, NICOTINIC ACID, Niacin, Niacin TD, Niaspan ER, Nicotinate, Simcor, WAMPOCAP | ||
View | 224 | NIACIN | Human | Clinical | Liver :: observation :: DILI | Pos | NIACIN, NIACOR, NIASPAN, NIASPAN TITRATION STARTER PACK, NICANGIN, NICOLAR, NICOTINIC ACID, Niacin, Niacin TD, Niaspan ER, Nicotinate, Simcor, WAMPOCAP | ||||
View | 224 | NIMESULIDE | Human | Clinical | Blood :: PK :: Cmax | Pos | 6.5 | µg/mL | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||
View | 224 | NIMESULIDE | Human | Clinical | Liver :: observation :: DILI | Pos | SID85231150, SID56422364, SID26746940, SID50103974, Nimesulide, SID11111521, SID26751468, R-805, SID11111520, SID124880853, SID855635 | ||||
View | 224 | NOMIFENSINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.136 | µg/mL | Alival, SID50105261, Merital, Nomifensine, SID90340560 | ||
View | 224 | NOMIFENSINE | Human | Clinical | Liver :: observation :: DILI | Pos | Alival, SID50105261, Merital, Nomifensine, SID90340560 | ||||
View | 224 | OXYPHENONIUM | Human | Clinical | Liver :: observation :: DILI | Neg | Oxyphenonium | ||||
View | 224 | PAROXETINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.02 | µg/mL | BRL-29060, Paroxetine, Paxil, SID50104981, SID26752262, SID144206674, SID50104978, SID50104979, SID50104980, SID29215051, SID90341371, Paxil [as hydrochloride], Pexeva | ||
View | 224 | PAROXETINE | Human | Clinical | Liver :: observation :: DILI | Neg | BRL-29060, Paroxetine, Paxil, SID50104981, SID26752262, SID144206674, SID50104978, SID50104979, SID50104980, SID29215051, SID90341371, Paxil [as hydrochloride], Pexeva | ||||
View | 224 | PERHEXILINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.6 | µg/mL | Perhexiline | ||
View | 224 | PERHEXILINE | Human | Clinical | Liver :: observation :: DILI | Pos | Perhexiline | ||||
View | 224 | PHENACETIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 2.4 | µg/mL | Phenacetin, SID11112166, Acetphenetidin, Acetophenetidin, SID144203898, SID124882016 | ||
View | 224 | PHENACETIN | Human | Clinical | Liver :: observation :: DILI | Pos | Phenacetin, SID11112166, Acetphenetidin, Acetophenetidin, SID144203898, SID124882016 | ||||
View | 224 | PHENYLBUTAZONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 150.0 | µg/mL | Elmedal, SID144203794, Pro-Bute, Azolid, SID17389760, Diphenylbutazone, Equiphar, SID50104199, SID85231197, Butaject, SID56436656, SID104171221, Butazolidin, Phenylbutazone, Antadol, SID855958, SID11111674, SID26751573, SID26747057, SID104171220, SID90341773 | ||
View | 224 | PHENYLBUTAZONE | Human | Clinical | Liver :: observation :: DILI | Pos | Elmedal, SID144203794, Pro-Bute, Azolid, SID17389760, Diphenylbutazone, Equiphar, SID50104199, SID85231197, Butaject, SID56436656, SID104171221, Butazolidin, Phenylbutazone, Antadol, SID855958, SID11111674, SID26751573, SID26747057, SID104171220, SID90341773 | ||||
View | 224 | PILOCARPINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0205 | µg/mL | Ocusert Pilo, Pilocarpine | ||
View | 224 | PILOCARPINE | Human | Clinical | Liver :: observation :: DILI | Neg | Ocusert Pilo, Pilocarpine | ||||
View | 224 | PIOGLITAZONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.05 | µg/mL | Actos, SID137275816, SID26756476, Pioglitazone, Duetact | ||
View | 224 | PIOGLITAZONE | Human | Clinical | Liver :: observation :: DILI | Neg | Actos, SID137275816, SID26756476, Pioglitazone, Duetact | ||||
View | 224 | PROGESTERONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0606 | µg/mL | CRINONE, Crinone, ENDOMETRIN, Endometrin, Gesterol, PROGESTERONE, PROMETRIUM, Progestasert, Progesterone, Progestin, Prometrium, Regumate, Syngestrone | ||
View | 224 | PROGESTERONE | Human | Clinical | Liver :: observation :: DILI | Pos | CRINONE, Crinone, ENDOMETRIN, Endometrin, Gesterol, PROGESTERONE, PROMETRIUM, Progestasert, Progesterone, Progestin, Prometrium, Regumate, Syngestrone | ||||
View | 224 | PROPRANOLOL | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.052 | µg/mL | Propranolol, SID26751802, Inderide-40/25, SID124881056, Innopran Xl, Inderal, SID50104497, Inderide-80/25, SID90341556, SID26755283 | ||
View | 224 | PROPRANOLOL | Human | Clinical | Liver :: observation :: DILI | Neg | Propranolol, SID26751802, Inderide-40/25, SID124881056, Innopran Xl, Inderal, SID50104497, Inderide-80/25, SID90341556, SID26755283 | ||||
View | 224 | PYRIMETHAMINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.818 | µg/mL | SID50100376, Pyrimethamine, Daraprim, Malacide, SID50104113, GNF-Pf-5586, Chloridin, TCMDC-123831, TCMDC-125860 | ||
View | 224 | RALOXIFENE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0005 | µg/mL | Evista, RALOXIFENE, Raloxifene | ||
View | 224 | RALOXIFENE | Human | Clinical | Liver :: observation :: DILI | Neg | Evista, RALOXIFENE, Raloxifene | ||||
View | 224 | ROSIGLITAZONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.373 | µg/mL | Avandaryl, Avandia, Rosiglitazone, SID26748954, SID144204987, Avandamet, BRL-49653 | ||
View | 224 | ROSIGLITAZONE | Human | Clinical | Liver :: observation :: DILI | Neg | Avandaryl, Avandia, Rosiglitazone, SID26748954, SID144204987, Avandamet, BRL-49653 | ||||
View | 224 | SERTRALINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0245 | µg/mL | SID50105685, SID50105684, Zoloft, SID50105682, SID49665783, SID90341218, SID29215139, Sertraline, SID26753299, SID50105683 | ||
View | 224 | SERTRALINE | Human | Clinical | Liver :: observation :: DILI | Neg | SID50105685, SID50105684, Zoloft, SID50105682, SID49665783, SID90341218, SID29215139, Sertraline, SID26753299, SID50105683 | ||||
View | 224 | SIMVASTATIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.01 | µg/mL | MK-733, Synvinolin, Simvastatin, Simvastatin hydroxy acid, SID496592, Zocor, SID50086525, SID144204247 | ||
View | 224 | SIMVASTATIN | Human | Clinical | Liver :: observation :: DILI | Neg | MK-733, Synvinolin, Simvastatin, Simvastatin hydroxy acid, SID496592, Zocor, SID50086525, SID144204247 | ||||
View | 224 | STAVUDINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.7764 | µg/mL | d4T, D4T, SID855856, Zerit Xr, BMY-27857, Stavudine, SID7971664, SID90341632, Zerit | ||
View | 224 | STAVUDINE | Human | Clinical | Liver :: observation :: DILI | Pos | d4T, D4T, SID855856, Zerit Xr, BMY-27857, Stavudine, SID7971664, SID90341632, Zerit | ||||
View | 224 | TAMOXIFEN | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.06 | µg/mL | Tamoxifen | ||
View | 224 | TAMOXIFEN | Human | Clinical | Liver :: observation :: DILI | Pos | Tamoxifen | ||||
View | 224 | TERFENADINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.5 | µg/mL | Triludan, SID144203846, Seldane, RMI-9918, SID90341346, SID56422373, SID85231279, Terfenadine, SID26752308, SID855647, Teldane, SID104171258, SID144203847, SID50105228 | ||
View | 224 | TERFENADINE | Human | Clinical | Liver :: observation :: DILI | Neg | Triludan, SID144203846, Seldane, RMI-9918, SID90341346, SID56422373, SID85231279, Terfenadine, SID26752308, SID855647, Teldane, SID104171258, SID144203847, SID50105228 | ||||
View | 224 | TETRACYCLINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 9.317 | µg/mL | Cyclopar, Vetquamycin, Panmycin, Achromycin, Liquamycin, E701, Tetracycline, Tetracyn | ||
View | 224 | TETRACYCLINE | Human | Clinical | Liver :: observation :: DILI | Pos | Cyclopar, Vetquamycin, Panmycin, Achromycin, Liquamycin, E701, Tetracycline, Tetracyn | ||||
View | 224 | TROGLITAZONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 2.82 | µg/mL | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||
View | 224 | TROGLITAZONE | Human | Clinical | Liver :: observation :: DILI | Pos | Rezulin, SID26757864, SID29216382, SID137275811, Gr92132X, SID26755242, Prelay, SID144205672, CS-045, GR-92132X, SID26755243, Troglitazone, CI-991 | ||||
View | 224 | WARFARIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.5 | µg/mL | SID26754489, Jantoven, SID50085958, Warfarin, SID26748308, Coumadin | ||
View | 224 | WARFARIN | Human | Clinical | Liver :: observation :: DILI | Neg | SID26754489, Jantoven, SID50085958, Warfarin, SID26748308, Coumadin | ||||
View | 224 | ZALCITABINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.0125 | µg/mL | Zalcitabine, SID50105404, SID90340765, SID49681781, SID50105405, Dideoxycytidine, Hivid, SID17389522, Ro-24-2027-000, DDC, SID11532889, SID144207040, Ro-242027000 | ||
View | 224 | ZALCITABINE | Human | Clinical | Liver :: observation :: DILI | Neg | Zalcitabine, SID50105404, SID90340765, SID49681781, SID50105405, Dideoxycytidine, Hivid, SID17389522, Ro-24-2027-000, DDC, SID11532889, SID144207040, Ro-242027000 | ||||
View | 224 | ZOMEPIRAC | Human | Clinical | Blood :: PK :: Cmax | Pos | 2.4 | µg/mL | Zomepirac, SID26752779, Zomax | ||
View | 224 | ZOMEPIRAC | Human | Clinical | Liver :: observation :: DILI | Neg | Zomepirac, SID26752779, Zomax | ||||
View | 224 | CAPTOPRIL | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.93 | µg/mL | CAPOTEN, CAPTOPRIL, Capoten, Captopril, Lopril, SQ 14,225, SQ-14225, Tensobon | ||
View | 224 | CHLORZOXAZONE | Human | Clinical | Blood :: PK :: Cmax | Pos | 0.457839 | µg/mL | Strifon Forte Dsc, Parafon Forte, Chlorzoxazone, Parafon Forte Dsc, Paraflex, SID11110946, Parafon, Strifon, Parafon-Forte, SID11110945 | ||
View | 224 | CHLORZOXAZONE | Human | Clinical | Liver :: observation :: DILI | Pos | Strifon Forte Dsc, Parafon Forte, Chlorzoxazone, Parafon Forte Dsc, Paraflex, SID11110946, Parafon, Strifon, Parafon-Forte, SID11110945 | ||||
View | 224 | CIMETIDINE | Human | Clinical | Blood :: PK :: Cmax | Pos | 1.14 | µg/mL | SID17389962, Cimetidine, Valmagen, SID104171130, SID11113773, SID90341189, SID26751957, SID50104629, SID460110, SID11533056, SID56462993, Brumetadina, Tagamet HB, SID26747359, Tagamet, Tagamet HB 200 | ||
View | 224 | CIMETIDINE | Human | Clinical | Liver :: observation :: DILI | Neg | SID17389962, Cimetidine, Valmagen, SID104171130, SID11113773, SID90341189, SID26751957, SID50104629, SID460110, SID11533056, SID56462993, Brumetadina, Tagamet HB, SID26747359, Tagamet, Tagamet HB 200 | ||||
View | 224 | DOXYCYCLINE HYCLATE | Human | Clinical | Blood :: PK :: Cmax | Pos | 5.0 | µg/mL | ATRIDOX, Alodox, DORYX, DOXY, DOXY 100, DOXY 200, DOXY-LEMMON, DOXYCHEL HYCLATE, DOXYCYCLINE HYCLATE, Doxy-Caps, PERIOSTAT, VIBRAMYCIN, Vibra-Tabs, Vibramycin Hyclate | ||
View | 224 | DOXYCYCLINE HYCLATE | Human | Clinical | Liver :: observation :: DILI | Pos | ATRIDOX, Alodox, DORYX, DOXY, DOXY 100, DOXY 200, DOXY-LEMMON, DOXYCHEL HYCLATE, DOXYCYCLINE HYCLATE, Doxy-Caps, PERIOSTAT, VIBRAMYCIN, Vibra-Tabs, Vibramycin Hyclate | ||||
View | 224 | HYDROXYUREA | Human | Clinical | Blood :: PK :: Cmax | Pos | 60.36 | µg/mL | SID26747533, SID50106399, Hydroxyurea, Droxia, Hydroxycarbamide, SID11111283, SQ-1089, Hydrea | ||
View | 224 | HYDROXYUREA | Human | Clinical | Liver :: observation :: DILI | Pos | SID26747533, SID50106399, Hydroxyurea, Droxia, Hydroxycarbamide, SID11111283, SQ-1089, Hydrea | ||||
View | 224 | TROVAFLOXACIN | Human | Clinical | Blood :: PK :: Cmax | Pos | 2.09 | µg/mL | Trovafloxacin, Turvel, Trovan | ||
View | 224 | TROVAFLOXACIN | Human | Clinical | Liver :: observation :: DILI | Pos | Trovafloxacin, Turvel, Trovan | ||||
View | 225 | Exemestane 25.0 mg | Human | Clinical | Multiple Organs :: Other :: No Toxicity | Progression Free Survival | Pos | ||||
View | 225 |
Exemestane
25.0
mg
EVEROLIMUS 10.0 mg |
Human | Clinical | Multiple Organs :: Other :: No Toxicity | Progression Free Survival | Pos | AFINITOR, AFINITOR DISPERZ, CERTICAN, EVEROLIMUS, RAD001, VOTUBIA, ZORTRESS | |||
View | 226 | LETROZOLE 2.5 mg | Human | Clinical | Multiple Organs :: Other :: No Toxicity | Progression Free Survival | Pos | SID124882709, Femara, CGS-20267, Letrozole, SID11112889 | |||
View | 226 | LETROZOLE 2.5 mg | Human | Clinical | Multiple Organs :: Other :: No Toxicity | Progression Free Survival | Pos | SID124882709, Femara, CGS-20267, Letrozole, SID11112889 | |||
View | 227 | Fulvestrant 500.0 mg | Human | Clinical | Multiple Organs :: Other :: No Toxicity | Progression Free Survival | Pos | ||||
View | 227 |
Fulvestrant
500.0
mg
Palbociclib 125.0 |
Human | Clinical | Multiple Organs :: Other :: No Toxicity | Progression Free Survival | Pos |